CMS MDS 3.0 User Manual

Download

Page 1

MDS 3.0 Quality Measures

USER’S MANUAL

(v14.0)

Effective October 1, 2020

Page 2

QUALITY MEASURES (QM) USER’S MANUAL

CONTENTS

MDS 3.0 Quality Measures USER’S MANUAL (v14.0) ....................................................... i

QUALITY MEASURES (QM) USER’S MANUAL CONTENTS ................................. i

NOTABLE CHANGES TO THE MDS QUALITY MEASURES (QM)

USER’S MANUAL V14 .........................................................................................1

Chapter 1 QM Sample and Record Selection Methodology ......................................................3

Section 1: Definitions .......................................................................................................3

Section 2: Selecting the QM Samples ...............................................................................5

Section 3: Short Stay Record Definitions .........................................................................7

Section 4: Long Stay Record Definitions .........................................................................9

Section 5: Transition from the Pressure Ulcer to Skin Integrity Quality

Measures ................................................................................................................12

Section 6: Transition to the Patient Driven Payment Model ..........................................12

Chapter 2 MDS 3.0 Quality Measures Logical Specifications ................................................15

Section 1: Short Stay (SS) Quality Measures .................................................................16

Table 2-1 Changes in Skin Integrity Post-Acute Care: Pressure

Ulcer/Injury ................................................................................................16

Table 2-2 Percent of Residents Who Were Assessed and Appropriately

Given the Seasonal Influenza Vaccine (SS) ..............................................17

Table 2-3 Percent of Residents Who Received the Seasonal Influenza

Vaccine (SS) ..............................................................................................18

Table 2-4 Percent of Residents Who Were Offered and Declined the

Seasonal Influenza Vaccine (SS) ...............................................................19

Table 2-5 Percent of Residents Who Did Not Receive, Due to Medical

Contraindication, the Seasonal Influenza Vaccine (SS) ............................20

Table 2-6 Percent of Residents Assessed and Appropriately Given the

Pneumococcal Vaccine (SS)21

Table 2-7 Percent of Residents Who Received the Pneumococcal

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 i

.....................................................................

Vaccine (SS

)

Page 3

Table 2-8 Percent of Residents Who Were Offered and Declined the

Pneumococcal Vaccine (SS)23

.....................................................................

Table 2-9 Percent of Residents Who Did Not Receive, Due to Medical

Contraindication, the Pneumococcal Vaccine (SS)

24...................................

Table 2-10 Percent of Residents Who Newly Received an Antipsychotic

Medication (SS) .........................................................................................25

Table 2-11 Percent of Residents Who Made Improvements in Function

(SS) ............................................................................................................27

Section 2: Long Stay (LS) Quality Measures .................................................................30

Table 2-12 Percent of Residents Experiencing One or More Falls with

Major Injury (LS) .......................................................................................30

Table 2-13 Percent of High-Risk Residents With Pressure Ulcers (LS) ...............31

Table 2-14 Percent of Residents Assessed and AppropriatelyGiven the

Seasonal Influenza Vaccine (LS) ...............................................................33

Table 2-15 Percent of Residents Who Received the Seasonal Influenza

Vaccine (LS) ..............................................................................................34

Table 2-16 Percent of Residents Who Were Offered and Declined the

Seasonal Influenza Vaccine (LS) ...............................................................35

Table 2-17 Percent of Residents Who Did Not Receive, Due to Medical

Contraindication, the Seasonal Influenza Vaccine (LS) ............................36

Table 2-18 Percent of Residents Assessed and Appropriately Given the

Pneumococcal Vaccine (LS) ......................................................................37

Table 2-19 Percent of Residents Who Received the Pneumococcal

Vaccine (LS) ..............................................................................................38

Table 2-20 Percent of Residents Who Were Offered and Declined the

Pneumococcal Vaccine (LS) ......................................................................39

Table 2-21 Percent of Residents Who Did Not Receive, Due to Medical

Contraindication, the Pneumococcal Vaccine (LS)40

...................................

Table 2-22 Percent of Residents with a Urinary Tract Infection (LS) ...................41

Table 2-23 Percent of Low Risk Residents Who Lose Control of Their

Bowel or Bladder (LS) ...............................................................................42

Table 2-24 Percent of Residents Who Have/Had a Catheter Inserted and

Left in Their Bladder (LS) .........................................................................44

Table 2-25 Percent of Residents Who Were Physically Restrained (LS) ..............46

Table 2-26 Percent of Residents Whose Need for Help with Activities of

Daily Living Has Increased (LS) ...............................................................47

Table 2-27 Percent of Residents Who Lose Too Much Weight (LS) ....................49

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 ii

Page 4

Table 2-28 Percent of Residents Who Have Depressive Symptoms (LS) .............50

Table 2-29 Percent of Residents Who Received an Antipsychotic

Medication (LS) .........................................................................................52

Table 2-30 Prevalence of Falls (LS) 53 ...........

...........

Tabel 2-31 Prevalence of Antianxiety/Hypnotic Use (LS)

Table 2-32 Prevalence of Behavior Symptoms Affecting Others (LS)56

...............................................

...................................

.....

............

Table 2-33 Percent of Residents Whose Ability to Move Independently

Worsene

d (LS) ...........................................................................................57

Table 2-34 Percent of Residents Who Used Antianxiety or Hypnotic

Medication (LS) .........................................................................................60

Chapter 3 Technical Details .....................................................................................................61

Quality Measures (QM) Technical Details .....................................................................62

Section 1 Introduction .....................................................................................................63

Section 2 Steps Used in National QM Calculation .........................................................65

Section 3 Calculation of the Expected QM Score ..........................................................69

Section 4 Calculation of the Adjusted QM Score ...........................................................72

Chapter 4 Parameters Used for Each Quarter ..........................................................................73

Table 4-1. Logistic Regression Coefficients .........................................................74

Table 4-2. National Observed QM Means ............................................................75

Chapter 5 Episode and Stay Determination Logic ...................................................................76

Table 5-1: Possible Entry Dates When Entry Record is Missing ..........................79

Chapter 6 Specifications for the Facility Characteristics Report .............................................83

Table 6-1: Facility Characteristics Report Measure Definitions ...........................85

APPENDIX A Quality Measure Identification Number by CMS Reporting Module..............1

Table A-1: Quality Measures (QMs) by CMS Reporting Module – Short

Stay ..............................................................................................................5

Table A-2: Quality Measures (QMs) by CMS Reporting Module – Long

Stay ..............................................................................................................7

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 iii

Page 5

NOTABLE CHANGES TO THE MDS QUALITY MEASURES (QM)

USER’S MANUAL V14

Transition from the Pressure Ulcer to Skin Integrity Measure

Beginning with the FY 2020 SNF QRP effective October 1, 2020, , Percent of Residents or Patients with Pressure Ulcers That Are New or Worsened (Short Stay) (CMS ID: S002.02) will be removed from the SNF QRP measure set and replaced with a modified version of that measure, Changes in Skin Integrity Post-Acute Care: Pressure Ulcer/Injury (CMS ID: S038.02), to include the addition of new or worsened unstageable pressure ulcers. This SNF QRP measure will also be reported as a part of the NHQI effective 10/01/2020. For additional details on this transition, please see Chapter 1 Section 5 of this manual.

Surveyor Quality Measures

The appendix on surveyor quality measures contained in previous versions of this user’s manual has been removed from MDS QM User’s Manual V14, and the measures have been relocated to Section 2 (Long Stay) of Chapter 2. Quality measure reports are available to State Surveyors and facility staff through CMS’s CASPER reporting system. Quality measures available to facilities through CASPER are also available to State Surveyors. Information regarding which measures are available in CASPER is located in the Quality Measure by CMS Reporting Module, located in Appendix A of this manual.

Measures Withdrawn from NQF Submission

The appendix on measures withdrawn from NQF submission contained in previous versions of this user’s manual has been removed from MDS QM User’s Manual V14, and the measures have been relocated to Section 1 (Short Stay) and Section 2 (Long Stay) of Chapter 2 respectively. The following list contains measures that were previously approved or given time limited endorsement by the National Quality Forum (NQF) but have been withdrawn from NQF submission. The specifications for the Short Stay measures withdrawn from NQF submission can be found in Chapter 2 Section 1 of this manual, and the specifications for the long stay measures withdrawn from NQF submission can be found in Chapter 2 Section 2 of this manual.

• Percent of Residents Assessed and Appropriately Given the Pneumococcal Vaccine

(Short Stay) (CMS: N007.02) (NQF #0682 withdrawn)

• Percent of Residents Who Received the Pneumococcal Vaccine

(Short Stay) (CMS: N008.02) (NQF #0682A withdrawn)

• Percent of Residents Who Were Offered and Declined the Pneumococcal Vaccine

(Short Stay) (CMS: N009.02) (NQF #0682B withdrawn)

• Percent of Residents Who Did Not Receive, Due to Medical Contraindication, the

Pneumococcal Vaccine (Short Stay) (CMS: N010.02) (NQF #0682C withdrawn)

• Percent of Residents Assessed and Appropriately Given the Pneumococcal Vaccine

(Long Stay) (CMS: N020.02) (NQF #0683 withdrawn)

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 1

Page 6

• Percent of Residents Who Received the Pneumococcal Vaccine

(Long Stay) (CMS: N021.02) (NQF #0683A withdrawn)

• Percent of Residents Who Were Offered and Declined the Pneumococcal Vaccine

(Long Stay) (CMS: N022.02) (NQF #0683B withdrawn)

• Percent of Residents Who Did Not Receive, Due to Medical Contraindication, the

Pneumococcal Vaccine (Long Stay) (CMS: N023.02) (NQF #0683C withdrawn)

• Percent of Residents Who Have Depressive Symptoms

(Long Stay) (CMS: N030.02) (NQF #0690 withdrawn)

• Percent of Low Risk Residents Who Lose Control of Their Bowel or Bladder

(Long Stay) (CMS: N025.02) (NQF #0685 withdrawn)

Renaming of Appendices

The Appendices contained in previous versions of this user’s manual have been renamed as chapters. The only Appendix (A) in the MDS QM User’s Manual V14 contains the Quality Measure Identification Number by CMS Reporting Module V1.8. The following list contains the new chapter names in this user’s manual paired with the associated appendix name from previous versions of this user’s manual:

• “Chapter 3: Technical Details,” previously “Appendix A: Technical Details”

• “Chapter 4: Parameters Used for Each Quarter,” previously “Appendix B: Parameters

Used for Each Quarter”

• “Chapter 5: Episode and Stay Determination Logic,” previously “Appendix C: Episode

and Stay Determination Logic”

• “Chapter 6: Specifications for the Facility Characteristics Report,” previously “Appendix

F: Specifications for the Facility Characteristics Report”

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 2

Page 7

Chapter 1

QM Sample and Record Selection Methodology

The purpose of this chapter is to describe the methodology that is used to select the short and long stay samples as well as the key records that are used to compute the QMs for each of those samples. The first section below will present definitions that are used to describe the selection methodology. The second section describes the selection of the two samples. The third and fourth sections describe the selection of the key records within each of the two samples.

The logic presented below depends upon the concepts of stays and episodes. Detailed specifications for the identification of stays and episodes are presented in Appendix C of this document.

Section 1: Definitions

Target period. The span of time that defines the QM reporting period (e.g., a calendar quarter).

Influenza Season. Influenza season is July 1 of the current year to June 30 of the following year

(e.g., July 1, 2019 through June 30, 2020 for the 2019 – 2020 influenza season).1

Stay. The period of time between a resident’s entry into a facility and either (a) a discharge, or (b) the end of the target period, whichever comes first. A stay, thus defined, may include interrupted stays lasting 3 calendar days or less. The start of a stay is either:

• An admission entry (A0310F = [01] and A1700 = [1]), or

• A reentry (A0310F = [01] and A1700 = [2]).

The end of a stay is the earliest of the following:

• Any discharge assessment (A0310F = [10, 11]), or

• A death in facility tracking record (A0310F = [12]), or

• The end of the target period.

Interrupted Stay. During a stay the resident had an interruption in their stay and resumed the same stay within three consecutive calendar days. Interrupted stays apply only to Medicarecovered stays and pertain to both short- and long-stay resident episodes.

This definition is applicable to each of the long- and short-stay influenza vaccination measures. The short-stay

measures are identified as the following: NQF #0680 (CMS ID: N003.03); NQF #0680A (CMS ID: N004.03); NQF #0680B (CMS ID: N005.03); NQF #0680C (CMS ID: N006.03). The long-stay measures are identified as the following: NQF #0681 (CMS ID: N016.03); NQF #0681A (CMS ID: N017.03); NQF #0681B (CMS ID: N018.03); NQF #0681C (CMS ID: N019.03).

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 3

Page 8

Episode. A period of time spanning one or more stays. An episode begins with an admission (defined below) and ends with either (a) a discharge, or (b) the end of the target period, whichever comes first. An episode starts with:

• An admission entry (A0310F = [01] and A1700 = [1]).

The end of an episode is the earliest of the following:

• A discharge assessment with return not anticipated (A0310F = [10]), or

• A discharge assessment with return anticipated (A0310F = [11]) but the resident did not

return within 30 days of discharge, or

• A death in facility tracking record (A0310F = [12]), or

• The end of the target period.

Admission. An admission entry record (A0310F = [01] and A1700 = [1]) is required when any one of the following occurs:

• Resident has never been admitted to this facility before; or

• Resident has been in this facility previously and was discharged return not anticipated; or

• Resident has been in this facility previously and was discharged return anticipated and

did not return within 30 days of discharge.

Reentry. A reentry record (A0310F = [01] and A1700 = [2]) is required when all of the following occurred prior to this entry; the resident was:

• Discharged return anticipated, and

• Returned to facility within 30 days of discharge.

Cumulative days in facility (CDIF). The total number of days within an episode during which the resident was in the facility. It is the sum of the number of days within each stay included in an episode. If an episode consists of more than one stay separated by periods of time outside the facility (e.g., hospitalizations), and/or one or more stays with interruptions lasting 3 calendar days or less, only those days within the facility would count towards CDIF. Any days outside of the facility (e.g., hospital, home, etc.) would not count towards the CDIF total. The following rules are used when computing CDIF:

• When counting the number of days until the end of the episode, counting stops with (a)

the last record in the target period if that record is a discharge assessment (A0310F = [10, 11]), (b) the last record in the target period if that record is a death in facility (A0310F = [12]), or (c) the end of the target period is reached, whichever is earlier.

• When counting the duration of each stay within an episode, include the day of entry

(A1600) but not the day of discharge (A2000) unless the entry and discharge occurred on the same day in which case the number of days in the stay is equal to 1.

o For example: if a resident is admitted on Monday and discharged the following

day (Tuesday), the duration of that episode would be 1 day.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 4

Page 9

• While death in facility records (A0310F = [12]) end CDIF counting, these records are not

used as target records because they contain only tracking information and do not include clinical information necessary for QM calculation.

• Special rules for influenza vaccination measures. Influenza vaccination measures are

calculated only once per 12-month influenza season, which begins July 1 of a given year and ends on June 30 of the subsequent year. For these measures, the target period begins on October 1 and ends on March 31. This means that the end-of-episode date will be March 31 for an episode that is ongoing at the end of the influenza season and that March 31 should be used as the end date when computing CDIF and for classifying stays as long or short for the influenza vaccination measures.

o Note, the target period (i.e., October 1 – March 31) is different than the selection

period, which begins October 1 and ends June 30 of the following year. The selection period for the influenza vaccination measures is discussed more in

Sections 3 and 4 below.

Short stay. An episode with CDIF less than or equal to 100 days as of the end of the target

period. Short stays may include one or more interruptions, indicated by Interrupted Stay (A0310G1 = [1]).

Long stay. An episode with CDIF greater than or equal to 101 days as of the end of the target period. Long stays may include one or more interruptions, indicated by Interrupted Stay (A0310G1 = [1]).

Target date. The event date for an MDS record, defined as follows:

• For an entry record (A0310F = [01]), the target date is equal to the entry date (A1600).

• For a discharge record (A0310F = [10, 11]) or death-in-facility record (A0310F = [12]),

the target date is equal to the discharge date (A2000).

• For all other records, the target date is equal to the Assessment Reference Date (ARD,

A2300).

Section 2: Selecting the QM Samples

Two resident samples are selected for computing the QMs: a short-stay sample and a long-stay sample. These samples are selected using the following steps:

1. Select all residents whose latest episode either ends during the target period or is ongoing

at the end of the target period. This latest episode is selected for QM calculation.

2. For each episode that is selected, compute the cumulative days in the facility (CDIF).

3. If the CDIF is less than or equal to 100 days, the resident is included in the short-stay

sample.

4. If the CDIF is greater than or equal to 101 days, the resident is included in the long-stay

sample.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 5

Page 10

Note that all residents who are selected in Step 1 above will be placed in either the short- or long-stay sample and that the two samples are mutually exclusive. If a resident has multiple episodes within the target period, only the latest episode is used.

Within each sample, certain key records are identified which are used for calculating individual measures. These records are defined in the following sections.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 6

Page 11

Section 3: Short Stay Record Definitions

ASSESSMENT

SELECTED PROPERTY

Target assessment

Initial assessment

Selection period Most recent 6 months (the short stay target period).

Qualifying RFAs2

Selection logic

Rationale

Selection period

Qualifying RFAs

Selection logic

Rationale

A0310A = [01, 02, 03, 04, 05, 06] or A0310B A0310F = [10, 11]

Latest assessment that meets the following criteria: (a) it is cont qualifying RFA, and (c) its target date is no more than 120 days before the end of the episode.

Records with a qualifying RFA contain all of the items needed to defi date within the target period, but it must occur within 120 days before the end of the resident’s selected episode (either the target date of a discharge assessment or death in facility record that is the last record in the target period or the end of the target period if the episode is ongoing). 120 days allows 93 days between quarterly assessments plus an additional 27 days to allow for late assessments. The target assessment represents the resident’s status at the end of the episode.

First assessment following the admission entry record at the beginni

A0310A = [01] or A0310B A0310F = [10, 11]

Earliest assessment that meets the following criteria: (a) it is cont qualifying RFA, (c) it has the earliest target date that is greater than or equal to the admission entry date starting the episode, and (d) its target date is no more than 130 days prior to the target date of the target record. The initial assessment cannot be the same as the target assessment. If the same assessment qualifies as both the initial and target assessments, it is used as the target assessment and the initial assessment is considered to be missing.

Records with a qualifying RFA contain all of the items needed to defi within the target period. The initial assessment represents the resident’s status as soon as possible after the admission that marks the beginning of the episode. If the initial assessment is more than 130 days prior to the target assessment, it is not used and the initial record is considered to be missing. This prevents the use of an initial assessment for a short stay in which a large portion of the resident’s episode was spent outside the facility. 130 days allows for as many as 30 days of a 100-day stay to occur outside of the facility.

= [01] or

ained within the resident’s selected episode, (b) it has a

ne the QMs. The target assessment need not have a target

ng of the resident’s selected episode.

= [01] or

ained within the resident’s selected episode, (b) it has a

ne the QMs. The initial assessment need not have a target date

(continued)

SELECTION SPECIFICATIONS

RFA: Reason For Assessment.

A short stay episode can span more than 100 calendar days because days outside of the facility are not counted in

defining a 100-day or less short stay episode.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 7

Page 12

Short Stay Record Definitions (continued)

ASSESSMENT

SELECTED PROPERTY SELECTION SPECIFICATIONS

Look-back Scan Selection period Scan all qualifying RFAs within the current episode.

Qualifying RFAs A0310A = [01, 02, 03, 04, 05, 06] or

Influenza vaccination assessment

A0310B = [01] A0310F = [10, 11]

Selection logic

Include the target assessment and qualifying earlier assessments in the scan. Include an earlier assessment in the scan if it meets all of the following conditions: (a) it is contained within the resident’s episode, (b) it has a qualifying RFA, and (c) its target date is on or before the target date for the target assessment. The target assessment and qualifying earlier assessments are scanned to determine whether certain events or conditions occurred during the look-back period. These events and conditions are specified in the definitions of measures that utilize the look-back scan.

Rationale Some measures utilize MDS items that record events or

conditions that occurred since the prior assessment was performed. The purpose of the look-back scan is to determine whether such events or conditions occurred during the lookback period. All qualifying RFAs with target dates within the episode are examined to determine whether the event or condition of interest occurred at any time during the episode.

Selection period

All assessments with target dates on or after October 1 of the most recently completed influenza season (i.e., the target date must be on or between October 1 of the current year and June 30 of the following year).

Qualifying RFAs

A0310A = [01, 02, 03, 04, 05, 06] or A0310B = [01] A0310F = [10, 11]

Selection logic Select the record with the latest target date that meets all of

the following conditions:

a) It has a qualifying RFA, and b) Target date is on or after October 1 of the most recently

c fall on or between October 1 and June 30), and

c) A1600 (entry date) is on or before March 31 of the most

recently completed influenza season.

Rationale The selection logic defined above is intended to identify the

latest assessment that reports the influenza vaccine status for a resident who was in the facility for at least one day from October 1 through March 31.

ompleted influenza season (i.e., the target date must

The selection period uses a June 30th end date to ensure residents who are vaccinated between October 1 and

March 31, but do not have an assessment completed until after March 31, are captured in the measure sample.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 8

Page 13

Section 4: Long Stay Record Definitions

ASSESSMENT

SELECTED PROPERTY

Target assessment Selection period Most recent 3 months (the long stay target period).

Qualifying RFAs A0310A = [01, 02, 03, 04, 05, 06] or

A0310B = [01] or A0310F = [10, 11]

Selection logic Latest assessment that meets the following criteria: (a) it is

contained within the resident’s selected episode, (b) it has a qualifying RFA, and (c) its target date is no more than 120 before the end of the episode.

Rationale Records with a qualifying RFA contain all of the items needed

to define the QMs. The target assessment need not have a target date within the target period, but it must occur within 120 days of the end of the resident’s episode (either the last discharge in the target period or the end of the target period if the episode is ongoing). 120 days allows 93 days between quarterly assessments plus an additional 27 days to allow for late assessments. The target assessment represents the resident’s status at the end of the episode.

Prior assessment Selection period Latest assessment that is 46 to 165 days before the target

assessment.

Qualifying RFAs A0310A = [01, 02, 03, 04, 05, 06] or

A0310B = [01] or A0310F = [10, 11]

Selection logic Latest assessment that meets the following criteria: (a) it is

contained within the resident’s episode, (b) it has a qualifying RFA, and (c) its target date is contained in the window that is 46 days to 165 days preceding the target date of the target assessment. If no qualifying assessment exists, the prior assessment is considered missing.

Rationale Records with a qualifying RFA contain all of the items needed

to define the QMs. The prior assessment need not have a target date within the target period, but it must occur within the defined window.

SELECTION SPECIFICATIONS

The window covers 120 days, which allows 93 days between

erly assessments plus an additional 27 days to allow for

quart late assessments. Requiring a 45-day gap between the prior assessment and the target assessment insures that the gap between the prior and target assessment will not be small (gaps of 45 days or less are excluded).

(continued)

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 9

Page 14

Long Stay Record Definitions (continued)

ASSESSMENT

SELECTED PROPERTY SELECTION SPECIFICATIONS

Look-back Scan Selection period Scan all qualifying RFAs within the current episode that have

target dates no more than 275 days prior to the target assessment.

Qualifying RFAs A0310A = [01, 02, 03, 04, 05, 06] or

A0310B = [01] A0310F = [10, 11]

Selection logic Include the target assessment and all qualifying earlier

assessments in the scan. Include an earlier assessment in the scan, if it meets all of the following conditions: (a) it is contained within the resident’s episode, (b) it has a qualifying RFA, (c) its target date is on or before the target date for the target assessment, and (d) its target date is no more than 275 days prior to the target date of the target assessment. The target assessment and qualifying earlier assessments are scanned to determine whether certain events or conditions occurred during the look-back period. These events and conditions are specified in the definitions of measures that utilize the look-back scan.

Rationale Some measures utilize MDS items that record events or

conditions that occurred since the prior assessment was performed. The purpose of the look-back scan is to determine whether such events or conditions occurred during the lookback period. These measures trigger if the event or condition of interest occurred any time during a one year period. A 275day time period is used to include up to three quarterly OBRA assessments. The earliest of these assessments would have a look-back period of up to 93 days, which would cover a total of about one year. All qualifying RFAs with target dates in this time period are examined to determine whether the event or condition of interest occurred at any time during the time interval.

(continued)

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 10

Page 15

Long Stay Record Definitions (continued)

ASSESSMENT

SELECTED PROPERTY SELECTION SPECIFICATIONS

Influenza vaccination assessment

Selection

period

Qualifying RFAs A0310A = [01, 02, 03, 04, 05, 06] or

Selection logic Select the record with the latest target date that meets all of

Rationale The selection logic defined above is intended to identify the

A0310B = [01] A0310F = [10, 11]

the following conditions:

a) It has a qualifying RFA, and b) Target date is on or after October 1 of the most recently

c fall on or between October 1 and June 30), and

c) A1600 (entry date) is on or before March 31 of the most

latest assessment that reports the influenza vaccine status for a resident who was in the facility for at least one day from October 1 through March 31.

ompleted influenza season (i.e., the target date must

ecently completed influenza season.

The selection period uses a June 30th end date to ensure residents who are vaccinated between October 1 and

March 31, but do not have an assessment completed until after March 31, are captured in the measure sample.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 11

Page 16

Section 5: Transition from the Pressure Ulcer to Skin Integrity Quality Measures

In order to reduce provider burden and duplication of measures, as well as to align measures across the NHQI and the Skilled Nursing Facility (SNF) Quality Reporting Program (QRP), the NHQI version of the quality measure, Percent of Residents or Patients with Pressure Ulcers That Are New or Worsened (Short Stay) (CMS ID: N002.04), was replaced with the SNF QRP version of the measure (CMS ID: S002.02) effective January 1, 2020. Beginning with the FY 2020 SNF QRP effective October 1, 2020, CMS ID: S002.02 will be removed from the SNF QRP measure set and replaced with a modified version of that measure, Changes in Skin Integrity Post-Acute Care: Pressure Ulcer/Injury (CMS ID: S038.02), to include the addition of new or worsened unstageable pressure ulcers. This SNF QRP measure will also be reported as a part of the NHQI effective 10/01/2020. The specifications for CMS ID: S038.02 can be found in the Skilled Nursing Facility Quality Reporting Program Measure Calculations and Reporting User’s Manual V3.0 on the SNF QRP website6 under the downloads section at the bottom of the page.

Section 6: Transition to the Patient Driven Payment Model

The Medicare PPS Patient Driven Payment Model (PDPM)7 became effective October 1, 20198. This payment change, including changes to the Medicare PPS assessment schedule and the introduction of interrupted stays, may have moderate to small impacts on measures that include Medicare Part A SNF stays that occur during a short-stay or long-stay episode. One example of a small measure impact is seen in the Percent of Residents Who Newly Received an Antipsychotic Medication (Short Stay) (NQF: None) (CMS ID: N011.02). The residents who are included in this measure may have Medicare Part A SNF stays that are used to calculate this measure; these stays may be ongoing while the PDPM policies become effective (i.e., Medicare Part A SNF stays with an admission prior to the effective date of October 1, 2019, and discharges on or after October 1, 2019). The remaining discussion refers to Medicare Part A SNF stays that are embedded within an episode.

For Medicare Part A SNF stays with an admission prior to the implementation date of October 1, 2019, and discharges on or after October 1, 2019, the Medicare Part A SNF stay will use the definitions and follow the measure specifications outlined in the MDS 3.0 QM User’s Manual Version 12.1 through September 30, 2019. Beginning October 1, 2019, the Medicare Part A SNF stay will use the definitions and follow the measure specifications outlined in the MDS 3.0 QM

Please refer to the Skilled Nursing Facility Quality Reporting Program Measure Calculations and Reporting User’s

Manual V3.0 on the SNF QRP website: https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-

struments/NursingHomeQualityInits/Skilled-Nursing-Facility-Quality-Reporting-Program/SNF-Quality-

In Reporting-Program-Measures-and-Technical-Information.html

The Patient Driven Payment Model was finalized under the FY 2019 SNF PPS final rule (83 FR 39183 through

39265). Please refer to the FY 2019 SNF PPS final rule: https://www.govinfo.gov/content/pkg/FR-2018-08-

08/pdf/2018-16570.pdf

Quality measure scores calculated using the new PDPM specifications were publicly reported as of April 2020.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 12

Page 17

User’s Manual Version 13.0. The information from all available qualifying RFAs throughout the episode may be used in the measure calculation. Two examples below illustrate this instruction:

• Resident entered the facility on August 1, 2019 and began a Medicare Part A SNF

stay on September 1, 2019 and was discharged from the Medicare Part A SNF stay on October 30, 2019

– The PPS 5-Day and PPS 14-Day Assessments are completed prior to the October

1, 2019 PDPM implementation date

– The PPS Discharge Assessment is completed after the October 1, 2019 PDPM

implementation date

o If the PPS 5-Day and PPS 14-Day Assessments are initial, prior, or target

assessments for a quality measure, then measure calculations would be based on QM specifications in the MDS 3.0 QM User’s Manual Version 12.1 for the PPS 5-Day and PPS 14-Day Assessments completed prior to October 1, 2019. If the PPS Discharge Assessment is an initial, a prior, or a target assessment for a quality measure, then measure calculations would be based on QM specifications in the MDS 3.0 QM User’s Manual Version 13.0 for the PPS Discharge Assessment which is completed after October 1, 2019 in this example. In this instance, if appropriate, measure calculations may utilize information from the PPS 5-Day, PPS 14-Day, and PPS Discharge Assessments because all assessments are valid Qualifying RFAs at the time the assessment was completed. OBRA assessments (stand-alone or combined with PPS assessments) may also be completed during the Medicare Part A SNF stay and used in measure calculations9.

• Rationale: The resident began the Medicare Part A SNF stay before

October 1, 2019. The measure specifications follow the instructions in the MDS 3.0 QM User’s Manual Version 12.1 for all assessments completed on or before September 30, 2019, which include PPS 14-Day Assessments.

• Resident entered the facility on September 1, 2019 and began a Medicare Part A SNF

stay on October 1, 2019 and was discharged from the Medicare Part A SNF stay on October 30, 2019

– PPS 5-Day and PPS Discharge Assessments are completed on or after the October

1, 2019 PDPM implementation date

o If the PPS 5-Day Assessment and/or PPS Discharge Assessment are initial,

prior, or target assessments for a quality measure, then measure calculations would be based on QM specifications in the MDS 3.0 QM User’s Manual Version 13.0. In this instance, if appropriate, measure calculations may utilize information from the PPS 5-Day and PPS Discharge Assessments because

Please refer to Chapter 1, Sections 3 and 4 to identify Qualifying RFAs for short and long stay measure

calculations.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 13

Page 18

those are the only PPS assessments that are valid Qualifying RFAs. OBRA assessments (stand-alone or combined with PPS assessments) may also be completed during the Medicare Part A SNF stay and used in measure calculations10.

• Rationale: The resident began the Medicare Part A SNF stay on or after

October 1, 2019. The measure specifications follow the instructions in the MDS 3.0 QM User’s manual Version 13.0, which, with respect to PPS assessments, only require a PPS 5-Day and PPS Discharge Assessment for quality measure calculations; all other interim PPS assessments used in quality measure calculations no longer exist under the PDPM. Note, Interim Payment Assessments (IPAs) are also part of the PPS item sets. If applicable, IPAs may also be completed during the Medicare Part A SNF stay; however, data from IPAs are used for PPS payment purposes only and are not used in measure calculations.

Please refer to Chapter 1, Sections 3 and 4 to identify Qualifying RFAs for short and long stay measure

calculations.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 14

Page 19

Chapter 2

MDS 3.0 Quality Measures Logical Specifications

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 15

Page 20

Section 1: Short Stay (SS) Quality Measures

Table 2-1

Changes in Skin Integrity Post-Acute Care: Pressure Ulcer/Injury11

(CMS ID: S038.02) (NQF: None)

This quality measure is calculated using the SNF Quality Reporting Program measure Changes in Skin Integrity Post-Acute Care: Pressure Ulcer/Injury (CMS ID: S038.02). To review the measure logic specifications for CMS ID: S038.02, please refer to the SNF Quality Reporting Program Measure Calculations and Reporting User’s Manual V3.0 on the SNF QRP website12 under the downloads section at the bottom of the page. The measure logical specifications can be found in Chapter 7, Table 7-5.

This measure is used in the Five-Star Quality Rating System.

Please refer to the SNF Quality Reporting Program Measure Calculations and Reporting User’s Manual V3.0 on the SNF QRP website:

https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/NursingHomeQualityInits/Skilled-Nursing-Facility-Quality-Reporting-

gram/SNF-Quality-Reporting-Program-Measures-and-Technical-Information.html

Pro

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 16

Page 21

Table 2-2

Percent of Residents Who Were Assessed and Appropriately Given the Seasonal Influenza Vaccine (SS)

(CMS ID: N003.03) (NQF #0680)

Measure Description

The measure reports the percent of short-stay residents who are assessed and/or given, appropriately, the influenza vaccination during the most recent influenza season.

Measure Specifications

Numerator

Residents meeting any of the following criteria on the selected influenza vaccination assessment:

1. Resident received the influenza vaccine during the most recent influenza season, either in the facility (O0250A = [1]) or outside the facility (O0250C

[2]); or

2. Resident was offered and declined the influenza vaccine (O0250C = [4]); or

3. Resident was ineligible due to medical contraindication(s) (O0250C = [3]) (e.g., anaphylactic hypersensitivity to eggs or other components of the

accine, history of Guillian-Barré Syndrome within 6 weeks after a previous influenza vaccination, bone marrow transplant within the past 6

months).

Denominator

All short-stay residents with a selected influenza vaccination assessment. This includes all residents who have an entry date (A1600) on or before March 31 of the most recently completed influenza season and have an assessment with a target date on or after October 1 of the most recently completed influenza season (i.e., the target date must fall on or between October 1 and June 30), except those with exclusions.

Exclusions

Resident’s age on target date of selected target assessment is 179 days or less.

Notes

This measure is only calculated once per 12-month influenza season which begins on July 1 of a given year and ends on June 30 of the subsequent year, and r

eports data for residents who were in the facility for at least one day during the target period of October 1 through March 31.

Not applicable.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 17

Covariates

Page 22

Table 2-3

Percent of Residents Who Received the Seasonal Influenza Vaccine (SS)

(CMS ID: N004.03) (NQF #0680A)

Measure Description

The measure reports the percent of short-stay residents who received the influenza vaccination during the most recent influenza season.

Measure Specifications

Numerator

Residents meeting the following criteria on the selected influenza vaccination assessment:

1. Resident received the influenza vaccine during the most recent influenza season, either in the facility (O0250A = [1]) or outside the facility (O0250C

[2]).

Denominator

All short-stay residents with a selected influenza vaccination assessment. This includes all residents who have an entry date (A1600) on or before March 31 of

he most recently completed influenza season and have an assessment with a target date on or after October 1 of the most recently completed influenza season

t (i.e., the target date must fall on or between October 1 and June 30), except those with exclusions.

Exclusions

Resident’s age on target date of selected target assessment is 179 days or less.

Notes

This measure is only calculated once per 12-month influenza season which begins on July 1 of a given year and ends on June 30 of the subsequent year and reports data for residents who were in the facility for at least one day during the target period of October 1 through March 31.

Not applicable.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 18

Covariates

Page 23

Table 2-4

Percent of Residents Who Were Offered and Declined the Seasonal Influenza Vaccine (SS)

(CMS ID: N005.03) (NQF #0680B)

Measure Description

The measure reports the percent of short-stay residents who are offered and declined the influenza vaccination during the most recent influenza season.

Measure Specifications

Numerator

Residents meeting the following criteria on the selected influenza vaccination assessment:

1. Resident was offered and declined the influenza vaccine during the most recent influenza season (O0250C = [4]).

Denominator

All short-stay residents with a selected influenza vaccination assessment. This includes all residents who have an entry date (A1600) on or before March 31 of

he most recently completed influenza season and have an assessment with a target date on or after October 1 of the most recently completed influenza season

t (i.e., the target date must fall on or between October 1 and June 30), except those with exclusions.

Exclusions

1. Resident’s age on target date of selected influenza vaccination assessment is 179 days or less.

Notes

Not applicable

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 19

Covariates

Page 24

Table 2-5

Percent of Residents Who Did Not Receive, Due to Medical Contraindication, the Seasonal Influenza Vaccine (SS)

(CMS ID: N006.03) (NQF #0680C)

Measure Description

The measure reports the percent of short-stay residents who did not receive, due to medical contraindication, the influenza vaccination during the most recent influenza season.

Measure Specifications

Numerator

Residents meeting the following criteria on the selected influenza vaccination assessment:

1. Resident was ineligible for the influenza vaccine during the most recent influenza season due to medical contraindication(s) (O0250C = [3]) (e.g.,

aphylactic hypersensitivity to eggs or other components of the vaccine, history of Guillian-Barré Syndrome within 6 weeks after a previous

an influenza vaccination, bone marrow transplant within the past 6 months).

Denominator

All short-stay residents with a selected influenza vaccination assessment. This includes all residents who have an entry date (A1600) on or before March 31 of

he most recently completed influenza season and have an assessment with a target date on or after October 1 of the most recently completed influenza season

t (i.e., the target date must fall on or between October 1 and June 30), except those with exclusions.

Exclusions

1. Resident’s age on target date of selected influenza vaccination assessment is 179 days or less.

Notes

This measure is only calculated once per 12-month influenza season which begins on July 1 of a given year and ends on June 30 of the subsequent year and r

eports data for residents who were in the facility for at least one day during the target period of October 1 through March 31

Not applicable

Covariates

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 20

Page 25

Table 2-6

Percent of Residents Assessed and Appropriately Given the Pneumococcal Vaccine (SS)

(CMS ID: N007.02) (NQF #0682 – Withdrawn)

Measure Description

This measure reports the percent of short-stay residents whose pneumococcal vaccine status is up to date during the 12-month reporting period.

Measure Specifications

Numerator

Residents meeting any of the following criteria on the selected target assessment:

1. Pneumococcal vaccine status is up to date (O0300A = [1]); or

2. Were offered and declined the vaccine (O0300B = [2]); or

3. Were ineligible due to medical contraindication(s) (O0300B = [1]) (e.g., anaphylactic hypersensitivity to components of the vaccine; bone marrow

ansplant within the past 12 months; or receiving a course of chemotherapy within the past two weeks).

Denominator

All short-stay residents with a selected target assessment.

Exclusions

Resident’s age on target date of selected target assessment is less than 5 years (i.e., resident has not yet reached fifth birthday on target date).

Not applicable

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 21

Covariates

Page 26

Table 2-7

Percent of Residents Who Received the Pneumococcal Vaccine (SS)

(CMS ID: N008.02) (NQF #0682A – Withdrawn)

Measure Description

This measure reports the percent of short-stay residents who received the pneumococcal vaccine during the 12-month reporting period.

Measure Specifications

Numerator

Residents meeting the following criteria on the selected target assessment:

1. Pneumococcal vaccine status is up to date (O0300A = [1]).

Denominator

All short-stay residents with a selected target assessment.

Exclusions

Resident’s age on target date of selected target assessment is less than 5 years (i.e., resident has not yet reached fifth birthday on target date).

Covariates

Not applicable

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 22

Page 27

Table 2-8

Percent of Residents Who Were Offered and Declined the Pneumococcal Vaccine (SS)

(CMS ID: N009.02) (NQF #0682B – Withdrawn)

Measure Description

This measure reports the percent of short-stay residents who were offered and declined the pneumococcal vaccine during the 12-month reporting period.

Measure Specifications

Numerator

Residents meeting the following criteria on the selected target assessment:

1. Were offered and declined the vaccine (O0300B = [2]).

Denominator

All short-stay residents with a selected target assessment.

Exclusions

Resident’s age on target date of selected target assessment is less than 5 years (i.e., resident has not yet reached fifth birthday on target date).

Covariates

Not applicable.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 23

Page 28

Table 2-9

Percent of Residents Who Did Not Receive, Due to Medical Contraindication, the Pneumococcal Vaccine (SS)

(CMS ID: N010.02) (NQF #0682C – Withdrawn)

Measure Description

This measure reports the percent of short-stay residents who did not receive, due to medical contraindication, the pneumococcal vaccine during the 12-month reporting period.

Measure Specifications

Numerator

Residents meeting the following criteria on the selected target assessment:

1. Were ineligible due to medical contraindication(s) (O0300B = [1]) (e.g., anaphylactic hypersensitivity to components of the vaccine; bone marrow

ransplant within the past 12 months; or receiving a course of chemotherapy within the past two weeks).

Denominator

All short-stay residents with a selected target assessment.

Exclusions

Resident’s age on target date of selected target assessment is less than 5 years (i.e., resident has not yet reached fifth birthday on target date).

Not applicable.

Covariates

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 24

Page 29

Table 2-10

Percent of Residents Who Newly Received an Antipsychotic Medication (SS)13

(CMS ID: N011.02) (NQF: None)

Measure Description

This measure reports the percentage of short-stay residents who are receiving an antipsychotic medication during the target period but not on their initial assessment.

Measure Specifications

Numerator

Short-stay residents for whom one or more assessments in a look-back scan (not including the initial assessment) indicates that antipsychotic medication was

ved:

recei

1. N0410A = [1, 2, 3, 4, 5, 6, 7].

Note that residents are excluded from this measure if their initial assessment indicates antipsychotic medication use or if antipsychotic medication use is

known on the initial assessment (see exclusion #3, below).

Denominator

ll short-stay residents who do not have exclusions and who meet all of the following conditions:

1. The resident has a target assessment, and

2. The resident has an initial assessment, and

3. The target assessment is not the same as the initial assessment.

Exclusions

he following is true for all assessments in the look-back scan (excluding the initial assessment):

1. T

1.1. For assessments with target dates on or after 04/01/2012: (N0410A = [-]).

2. Any of the following related conditions are present on any assessment in a look-back scan:

2.1. Schizophrenia (I6000 = [1]).

2.2. Tourette’s syndrome (I5350 = [1]).

2.3. Huntington’s disease (I5250 = [1]).

This measure is used in the Five-Star Quality Rating System

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 25

Page 30

Measure Specifications Continued

3. The resident’s initial assessment indicates antipsychotic medication use or antipsychotic medication use is unknown:

3.1. For initial assessments with target dates on or after 04/01/2012: (N0410A = [1, 2, 3, 4, 5, 6, 7, -]).

Covariates

Not applicable

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 26

Page 31

Table 2-11

Percent of Residents Who Made Improvements in Function (SS)14

(CMS ID: N037.03) (NQF: None)

Measure Description

This measure reports the percentage of short-stay residents who were discharged from the nursing home that gained more independence in transfer, locomotion, and walking during their episodes of care.

Measure Specifications

NOTE:

1. A “valid preceding PPS 5-Day assessment or OBRA Admission assessment” refers to the date of the earliest assessment if a resident has both a PPS

Day assessment (A0310B = [01]) and an OBRA Admission assessment (A0310A = [01]).

2. A “valid discharge assessment” refers to a discharge assessment with a date closest to the valid preceding PPS 5-Day assessment or OBRA

Admission assessment where a return is not anticipated (A0310F = [10]).

3. The PPS 5-Day assessment or OBRA Admission assessment should be used to calculate the tercile cutoffs. If resident has both a PPS 5-Day

ass

essment and an OBRA Admission assessment, calculate covariate using the assessment with the earlier date. Terciles are recalculated in each

quarter.

Numerator

Short-stay residents who:

1. Have a change in performance score that is negative ([valid discharge assessment] - [valid preceding PPS 5-Day assessment or OBRA Admission

ass

essment] < [0]).

Performance is calculated as the sum of G0110B1 (transfer: self- performance), G0110E1 (locomotion on unit: self-performance), and G0110D1 (walk in corridor: self-performance), with 7’s (activity occurred only once or twice) and 8's (activity did not occur) recoded to 4's (total dependence).

Denominator

Short-stay residents who meet all of the following conditions, except those with exclusions:

1. Have a valid discharge assessment (A0310F = [10]), and

2. Have a valid preceding PPS 5-Day assessment (A0310B = [01]) or OBRA Admission assessment (A0310A = [01]).

This measure is used in the Five-Star Quality Rating System.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 27

Page 32

Measure Specifications Continued

Exclusions

1. Residents satisfying any of the following conditions:

1.1. Comatose (B0100 = [1]) on the PPS 5-Day assessment or OBRA Admission assessment, whichever was used in the QM.

1.2. Life expectancy of less than 6 months (J1400 = [1]) on the PPS 5-Day assessment or OBRA Admission assessment, whichever was used in the

1.3. Hospice (O0100K2 = [1]) on the PPS 5-Day assessment or OBRA Admission assessment, whichever was used in the QM.

1.4. Information on Transfer: self-performance, walk in corridor: self-performance, or locomotion on unit: self-performance is missing on any of the

sessments used to calculate the QM (G0110B1, G0110D1, or G0110E1 = [-]) (i.e., valid discharge assessment, and PPS 5-Day assessment or

OBRA Admission assessment, whichever was used in the QM).

1.5. Residents with no impairment (sum of G0110B1, G0110D1 and G0110E1 = [0]) on the PPS 5-Day assessment or OBRA Admission

assessment, whichever was used in the QM.

1.6. Residents with an unplanned discharge on any assessment during the care episode (A0310G = [2])

Covariates

All covariates used throughout this measure are calculated using the valid preceding PPS 5-Day assessment or OBRA Admission assessment described in the NOTE at the top of the measure specifications.

1. Age on t

(A0900) from the date of assessment (A2300)

If (MONTH(A2300) > MONTH(A0900)) or (MONTH(A2300) = MONTH(A0900) and

DAY(A2300) >= DAY(A0900)) then Age = YEAR(A2300)-YEAR(A0900) else Age = YEAR(A2300)-YEAR(A0900)-1

1.1 Covariate Age Category ≤ 54 = 1 if Age ≤ 54 and Covariate Age Category ≤ 54 = 0 if Age >54)

1.2 Covariate Age Category 54 to 84 = 1 if Age >54 and ≤ 84 and Covariate Age Category 54 to 84 = 0 if Age ≤ 54 or Age > 84) (reference)

1.3 Covariate Age Category >84 = 1 if Age >84 and Covariate Age Category >84 = 0 if Age ≤ 84)

2. Gender

2.1 Covariate = 1 if (A0800 = [2]) (Female)

2.2 Covariate = 0 if (A0800 = [1]) (Male)

3. Severe cognitive impairment

3.1 Covariate = 1 if (C1000 = [3] and C0700 = [1]) or BIMS summary score (C0500) < [7]

3.2 Covariate = 0 if (C1000 = [0, 1, 2, ^, -] or C0700 = [0, ^, -]) and (C0500 = [>7, ^, -, 99])

4. Long Form ADL (LFADL) Scale (G0110A1 + G0110B1 + G0110E1 + G0110G1 + G0110H1 + G0110I1 + G0110J1). If any (G0110A1, G0110B1,

he PPS 5-Day assessment (A0310B = [01]) or OBRA Admission assessment (A0310A = [01]) as calculated by subtracting date of birth

If Covariate has not been set to 1 or 0 based on logic in 3.1 and 3.2, then Covariate = [0].

0110E1, G0110G1, G0110H1, G0110I1, G0110J1) = [7, 8], recode the item to equal [4].

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 28

Page 33

4.1 Covariate = 0 if LFADL = (middle tercile15 or highest tercile) or if any (G0110A1, G0110B1, G0110E1, G0110G1, G0110H1, G0110I1,

G0110J1) = [-]

Covariate = 1 if LFADL = lowest tercile

4.2 Covariate =0 if (lowest tercile or highest tercile)

ovariate = 1 if LFADL = middle tercile (reference)

4.3 Covariate =0 if (lowest tercile or middle tercile)

ovariate = 1 if LFADL = highest tercile

5. Heart failure

5.1 Covariate = 1 if (I0600 = [1])

ovariate = 0 if (I0600 = [0, -])

6. CVA, TIA, or Stroke

6.1 Covariate = 1 if (I4500 = [1])

ovariate = 0 if (I4500 = [0, -])

7. Hip Fracture

7.1 Covariate = 1 if (I3900 = [1])

ovariate = 0 if (I3900 = [0, -])

8. Other Fracture

8.1 Covariate = 1 if (I4000 = [1])

ovariate = 0 if (I4000 = [0, -])

Covariates Continued

Long Form ADL Scale terciles are recalculated in each quarter using the PPS 5-Day or OBRA Admission assessment.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 29

Page 34

Section 2: Long Stay (LS) Quality Measures

Table 2-12

Percent of Residents Experiencing One or More Falls with Major Injury (LS)16

(CMS ID: N013.02) (NQF: 0674)

Measure Description

This measure reports the percent of long-stay residents who have experienced one or more falls with major injury reported in the target period or look-back period.

Measure Specifications

Numerator

Long-stay residents with one or more look-back scan assessments that indicate one or more falls that resulted in major injury (J1900C = [1, 2]).

Denominator

All long-stay nursing home residents with one or more look-back scan assessments except those with exclusions.

Exclusions

esident is excluded if the following is true for all look-back scan assessments:

1. The number of falls with major injury was not coded (J1900C = [-]).

Not applicable.

This measure is used in the Five-Star Quality Rating System.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 30

Covariates

Page 35

Table 2-13

Percent of High-Risk Residents With Pressure Ulcers (LS)17

(CMS ID: N015.03) (NQF: 0679)

Measure Description

This measure captures the percentage of long-stay, high-risk residents with Stage II-IV or unstageable pressure ulcers

Measure Specifications

Numerator

All long-stay residents with a selected target assessment that meet the following condition:

1. Stage II-IV or unstageable pressure ulcers are present, as indicated by any of the following six conditions:

1.1. (M0300B1 = [1, 2, 3, 4, 5, 6, 7, 8, or 9]) or

1.2. (M0300C1 = [1, 2, 3, 4, 5, 6, 7, 8, or 9]) or

1.3. (M0300D1 = [1, 2, 3, 4, 5, 6, 7, 8, or 9]) or

1.4. (M0300E1 = [1, 2, 3, 4, 5, 6, 7, 8, or 9]) or

1.5. (M0300F1 = [1, 2, 3, 4, 5, 6, 7, 8, or 9]) or

1.6. (M0300G1 = [1, 2, 3, 4, 5, 6, 7, 8, or 9]).

Denominator

All long-stay residents with a selected target assessment who meet the definition of high risk, except those with exclusions. Residents are defined as high-risk

hey meet one or more of the following three criteria on the target assessment:

if t

1. Impaired bed mobility or transfer indicated, by either or both of the following:

1.1. Bed mobility, self-performance (G0110A1 = [3, 4, 7, 8]).

1.2. Transfer, self-performance (G0110B1 = [3, 4, 7, 8]).

2. Comatose (B0100 = [1]).

3. Malnutrition or at risk of malnutrition (I5600 = [1]) (checked).

This measure is used in the Five-Star Quality Rating System.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 31

Page 36

Measure Specifications Continued

Exclusions

1. Target assessment is an OBRA Admission assessment (A0310A = [01]) or a PPS 5-Day assessment (A0310B = [01]).

2. If the resident is not included in the numerator (the resident did not meet the pressure ulcer conditions for the numerator) and any of the following

onditions are true:

2.1. (M0300B1 = [-]).

2.2. (M0300C1 = [-]).

2.3. (M0300D1 = [-]).

2.4. (M0300E1 = [-]).

2.5. (M0300F1 = [-]).

2.6. (M0300G1 = [-]).

Covariates

Not applicable.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 32

Page 37

Table 2-14

Percent of Residents Assessed and AppropriatelyGiven the Seasonal Influenza Vaccine (LS)

(CMS ID: N016.03) (NQF #0681)

Measure Description

The measure reports the percent of long-stay residents who are assessed and/or given, appropriately, the influenza vaccination during the most recent influenza season.

Measure Specifications

Numerator

Residents meeting any of the following criteria on the selected influenza vaccination assessment:

1. Resident received the influenza vaccine during the most recent influenza season, either in the facility (O0250A= [1]) or outside the facility

O0250C = [2]); or

(

2. Resident was offered and declined the influenza vaccine (O0250C = [4]); or

3. Resident was ineligible due to medical contraindication(s) (O0250C = [3]) (e.g., anaphylactic hypersensitivity to eggs or other components of the

accine, history of Guillian-Barré Syndrome within 6 weeks after a previous influenza vaccination, bone marrow transplant within the past 6

months).

Denominator

All long-stay residents with a selected influenza vaccination assessment. This includes all residents who have an entry date (A1600) on or before March 31 of

he most recently completed influenza season and have an assessment with a target date on or after October 1 of the most recently completed influenza season

t (i.e., the target date must fall on or between October 1 and June 30), except those with exclusions.

Exclusions

Resident’s age on target date of selected influenza vaccination assessment is 179 days or less.

Notes

Covariates

Not applicable.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 33

Page 38

Table 2-15

Percent of Residents Who Received the Seasonal Influenza Vaccine (LS)

(CMS ID: N017.03) (NQF #0681A)

Measure Description

The measure reports the percent of long-stay residents who received the influenza vaccination during the most recent influenza season.

Measure Specifications

Numerator

Residents meeting the following criteria on the selected influenza vaccination assessment:

1. Resident received the influenza vaccine during the most recent influenza season, either in the facility (O0250A = [1]) or outside the facility (O0250C

[2]).

Denominator

All long-stay residents with a selected influenza vaccination assessment. This includes all residents who have an entry date (A1600) on or before March 31 of

he most recently completed influenza season and have an assessment with a target date on or after October 1 of the most recently completed influenza season

t (i.e., the target date must fall on or between October 1 and June 30), except those with exclusions.

Exclusions

Resident’s age on target date of selected influenza vaccination assessment is 179 days or less.

Notes

Not applicable.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 34

Covariates

Page 39

Table 2-16

Percent of Residents Who Were Offered and Declined the Seasonal Influenza Vaccine (LS)

(CMS ID: N018.03) (NQF #0681B)

Measure Description

The measure reports the percent of long-stay residents who are offered and declined the influenza vaccination during the most recent influenza season.

Measure Specifications

Numerator

Residents meeting the following criteria on the selected influenza vaccination assessment:

1. Resident was offered and declined the influenza vaccine during the most recent influenza season (O0250C = [4]).

Denominator

All long-stay residents with a selected influenza vaccination assessment. This includes all residents who have an entry date (A1600) on or before March 31 of

he most recently completed influenza season and have an assessment with a target date on or after October 1 of the most recently completed influenza season

t (i.e., the target date must fall on or between October 1 and June 30), except those with exclusions.

Exclusions

Resident’s age on target date of selected influenza vaccination assessment is 179 days or less.

Notes

Not applicable.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 35

Covariates

Page 40

Table 2-17

Percent of Residents Who Did Not Receive, Due to Medical Contraindication, the Seasonal Influenza Vaccine (LS)

(CMS ID: N019.03) (NQF #0681C)

Measure Description

The measure reports the percent of long-stay residents who did not receive, due to medical contraindication, the influenza vaccination during the most recent influenza season.

Measure Specifications

Numerator

Residents meeting the following criteria on the selected influenza vaccination assessment:

1. Resident was ineligible for the influenza vaccine during the most recent influenza season due to medical contraindication(s) (O0250C = [3]) (e.g.,

aphylactic hypersensitivity to eggs or other components of the vaccine, history of Guillain-Barré Syndrome within 6 weeks after a previous

an influenza vaccination, bone marrow transplant within the past 6 months).

Denominator

All long-stay residents with a selected influenza vaccination assessment. This includes all residents who have an entry date (A1600) on or before March 31 of

he most recently completed influenza season and have an assessment with a target date on or after October 1 of the most recently completed influenza season

t (i.e., the target date must fall on or between October 1 and June 30), except those with exclusions.

Exclusions

Resident’s age on target date of selected influenza vaccination assessment is 179 days or less.

Notes

This measure is only calculated once per 12-month influenza season which begins on July 1 of a given year and ends on June 30 of the subsequent year and r

eports data for residents who were in the facility for at least one day during the target period of October 1 through March 31.

Not applicable.

Covariates

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 36

Page 41

Table 2-18

Percent of Residents Assessed and Appropriately Given the Pneumococcal Vaccine (LS)

(CMS ID: N020.02) (NQF #0683 – Withdrawn)

Measure Description

This measure reports the percent of long-stay residents whose pneumococcal vaccine status is up to date.

Measure Specifications

Numerator

Residents meeting any of the following criteria on the selected target assessment:

1. Have an up to date pneumococcal vaccine status (O0300A = [1]); or

2. Were offered and declined the vaccine (O0300B = [2]); or

3. Were ineligible due to medical contraindication(s) (e.g., anaphylactic hypersensitivity to components of the vaccine; bone marrow transplant within

he past 12 months; or receiving a course of chemotherapy within the past two weeks) (O0300B = [1]).

Denominator

All long-stay residents with a selected target assessment.

Covariates

Not applicable.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 37

Page 42

Table 2-19

Percent of Residents Who Received the Pneumococcal Vaccine (LS)

(CMS ID: N021.02) (NQF #0683A – Withdrawn)

Measure Description

This measure reports the percent of long-stay residents who received the pneumococcal vaccine during the 12-month reporting period.

Measure Specifications

Numerator

Residents meeting the following criteria on the selected target assessment:

1. Pneumococcal vaccine status is up to date (O0300A = [1]).

Denominator

All long-stay residents with a selected target assessment.

Covariates

Not applicable.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 38

Page 43

Table 2-20

Percent of Residents Who Were Offered and Declined the Pneumococcal Vaccine (LS)

(CMS ID: N022.02) (NQF #0683B – Withdrawn)

Measure Description

This measure reports the percent of long-stay residents who were offered and declined the pneumococcal vaccine during the 12-month reporting period.

Measure Specifications

Numerator

Residents meeting the following criteria on the selected target assessment:

1. Were offered and declined the vaccine (O0300B = [2]).

Denominator

All long-stay residents with a selected target assessment.

Covariates

Not applicable.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 39

Page 44

Table 2-21

Percent of Residents Who Did Not Receive, Due to Medical Contraindication, the Pneumococcal Vaccine (LS)

(CMS ID: N023.02) (NQF #0683C – Withdrawn)

Measure Description

This measure reports the percent of long-stay residents who did not receive, due to medical contraindication, the pneumococcal vaccine during the 12-month reporting period.

Measure Specifications

Numerator

Residents meeting the following criteria on the selected target assessment:

1. Were ineligible due to medical contraindication(s) (O0300B = [1]) (e.g., anaphylactic hypersensitivity to components of the vaccine; bone marrow

ransplant within the past 12 months; or receiving a course of chemotherapy within the past two weeks).

Denominator

All long-stay residents with a selected target assessment.

Covariates

Not applicable.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 40

Page 45

Table 2-22

Percent of Residents with a Urinary Tract Infection (LS)18

(CMS ID: N024.02) (NQF: 0684)

Measure Description

The measure reports the percentage of long stay residents who have a urinary tract infection.

Measure Specifications

Numerator

Long-stay residents with a selected target assessment that indicates urinary tract infection within the last 30 days (I2300 = [1]).

Denominator

All long-stay residents with a selected target assessment, except those with exclusions.

Exclusions

1. Target assessment is an admission assessment (A0310A = [01]) or a PPS 5-Day assessment (A0310B = [01]).

2. Urinary tract infection value is missing (I2300 = [-]).

Covariates

Not applicable.

This measure is used in the Five-Star Quality Rating System.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 41

Page 46

Table 2-23

Percent of Low Risk Residents Who Lose Control of Their Bowel or Bladder (LS)

(CMS ID: N025.02) (NQF #0685 – Withdrawn)

Measure Description

The measure reports the percent of long-stay residents who frequently lose control of their bowel or bladder.

Measure Specifications

Numerator

Long-stay residents with a selected target assessment that indicates frequently or always incontinence of the bladder (H0300 = [2, 3]) or bowel (H0400 = [2,

]).

Denominator

All long-stay residents with a selected target assessment, except those with exclusions.

Exc

lusions

1. Target assessment is an admission assessment (A0310A = [01]) or a PPS 5-Day assessment (A0310B = [01]).

2. Resident is not in numerator and H0300 = [-] or H0400 = [-].

3. Residents who have any of the following high-risk conditions:

3.1. Severe cognitive impairment on the target assessment as indicated by (C1000 = [3] and C0700 = [1]) or (C0500 ≤ [7]).

3.2. Totally dependent in bed mobility self-performance (G0110A1 = [4, 7, 8]).

3.3. Totally dependent in transfer self-performance (G0110B1 = [4, 7, 8]).

3.4. Totally dependent in locomotion on unit self-performance (G0110E1 = [4, 7, 8]).

4. Resident does not qualify as high risk (see #3 above) and both of the following two conditions are true for the target assessment:

4.1. C0500 = [99, ^, -], and

4.2. C0700 = [^, -] or C1000 = [^, -].

5. Resident does not qualify as high risk (see #3 above) and any of the following three conditions are true:

5.1. G0110A1 = [-].

5.2. G0110B1 = [-].

5.3. G0110E1 = [-].

6. Resident is comatose (B0100 = [1]) or comatose status is missing (B0100 = [-]) on the target assessment.

7. Resident has an indwelling catheter (H0100A = [1]) or indwelling catheter status is missing (H0100A = [-]) on the target assessment.

8. Resident has an ostomy (H0100C = [1]) or ostomy status is missing (H0100C = [-]) on the target assessment.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 42

Page 47

Not applicable.

Covariates

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 43

Page 48

Table 2-24

Percent of Residents Who Have/Had a Catheter Inserted and Left in Their Bladder (LS)19

(CMS ID: N026.03) (NQF #0686)

Measure Description

This measure reports the percentage of residents who have had an indwelling catheter in the last 7 days.

Measure Specifications

Numerator

Long-stay residents with a selected target assessment that indicates the use of indwelling catheters (H0100A = [1]).

Denominator

All long-stay residents with a selected target assessment, except those with exclusions.

Exclusions

1. Target assessment is an admission assessment (A0310A = [01]) or a PPS 5-Day assessment (A0310B = [01]).

2. Target assessment indicates that indwelling catheter status is missing (H0100A = [-]).

3. Target assessment indicates neurogenic bladder (I1550 = [1]) or neurogenic bladder status is missing (I1550 = [-]).

4. Target assessment indicates obstructive uropathy (I1650 = [1]) or obstructive uropathy status is missing (I1650 = [-]).

1. Frequent bowel incontinence on prior assessment (H0400 = [2, 3]).

1.1. Covariate = [1] if (H0400 = [2, 3]).

1.2. Covariate = [0] if (H0400 = [0, 1, 9, -]).

2. Pressure ulcers at stages II, III, or IV on prior assessment:

2.1. Covariate = [1] if any of the following are true:

2.1.1. (M0300B1 = [1, 2, 3, 4, 5, 6, 7, 8, 9]), or

2.1.2. (M0300C1 = [1, 2, 3, 4, 5, 6, 7, 8, 9]), or

2.1.3. (M0300D1 = [1, 2, 3, 4, 5, 6, 7, 8, 9]).

2.2. Covariate = [0] if the following is true:

This measure is used in the Five-Star Quality Rating System.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 44

Covariates

Page 49

2.2.1. (M0300B1 = [0, -, ^]) and

2.2.2. (M0300C1 = [0, -, ^]) and

2.2.3. (M0300D1 = [0, -, ^]).

3. All covariates are missing if no prior assessment is available.

Covariates Continued

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 45

Page 50

Table 2-25

Percent of Residents Who Were Physically Restrained (LS)

(CMS ID: N027.02) (NQF #0687)

Measure Description

This measure reports the percent of long-stay nursing facility residents who are physically restrained on a daily basis.

Measure Specifications

Numerator

Long-stay residents with a selected target assessment that indicates daily physical restraints,

here:

1. Trunk restraint used in bed (P0100B = [2]), or

2. Limb restraint used in bed (P0100C = [2]), or

3. Trunk restraint used in chair or out of bed (P0100E = [2]), or

4. Limb restraint used in chair or out of bed (P0100F = [2]), or

5. Chair prevents rising used in chair or out of bed (P0100G) = [2]).

Denominator

All long-stay residents with a target assessment, except those with exclusions.

Exclusions

Resident is not in numerator and any of the following is true:

1. (P0100B = [-]), or

2. (P0100C = [-]), or

3. (P0100E = [-]), or

4. (P0100F = [-]), or

5. (P0100G = [-]).

Not applicable.

Covariates

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 46

Page 51

Table 2-26

Percent of Residents Whose Need for Help with Activities of Daily Living Has Increased (LS)20

(CMS ID: N028.02) (NQF: None)

Measure Description

This measure reports the percent of long-stay residents whose need for help with late-loss Activities of Daily Living (ADLs) has increased when compared to the prior assessment.

Measure Specifications

Numerator

Long-stay residents with selected target and prior assessments that indicate the need for help with late-loss Activities of Daily Living (ADLs) has increased

en the selected assessments are compared. The four late-loss ADL items are self-performance bed mobility (G0110A1), self-performance transfer

wh (G0110B1), self-performance eating (G0110H1), and self-performance toileting (G0110I1).

An increase is defined as an increase in two or more coding points in one late-loss ADL item or one point increase in coding points in two or more late-loss AD

L items. Note that for each of these four ADL items, if the value is equal to [7, 8] on either the target or prior assessment, then recode the item to equal [4]

to allow appropriate comparison.

Residents meet the definition of increased need of help with late-loss ADLs if either of the following are true

1. At least two of the following are true (note that in the notation below, [t] refers to the target assessment, and [t-1] refers to the prior assessment):

1.1 Bed mobility: ([Level at target assessment (G0110A1[t])] - [Level at prior assessment (G0110A1[t-1])]) > [0], or

1.2 Transfer: ([Level at target assessment (G0110B1[t])] - [Level at prior assessment (G0110B1[t-1])]) > [0], or

1.3 Eating: ([Level at target assessment (G0110H1[t])] - [Level at prior assessment (G0110H1[t-1])]) > [0], or

1.4 Toileting: ([Level at target assessment (G0110I1[t])] - [Level at prior assessment (G0110I1[t-1])]) > [0].

2. At least one of the following is true:

2.1 Bed mobility: ([Level at target assessment (G0110A1[t])] - [Level at prior assessment (G0110A1[t-1])]) > [1], or

2.2 Transfer: ([Level at target assessment (G0110B1[t])] - [Level at prior assessment (G0110B1[t-1])]) > [1], or

2.3 Eating: ([Level at target assessment (G0110H1[t])] - [Level at prior assessment (G0110H1[t-1])]) > [1], or

2.4 Toileting: ([Level at target assessment (G0110I1[t])] - [Level at prior assessment (G0110I1[t-1])]) > [1].

This measure is used in the Five-Star Quality Rating System.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 47

Page 52

Measure Specifications Continued

Denominator

All long-stay residents with a selected target and prior assessment, except those with exclusions.

Exclusions

1. All four of the late-loss ADL items indicate total dependence on the prior assessment, as indicated by:

1.1. Bed Mobility (G0110A1) = [4, 7, 8] and

1.2. Transferring (G0110B1) = [4, 7, 8] and

1.3. Eating (G0110H1) = [4, 7, 8] and

1.4. Toileting (G0110I1) = [4, 7, 8].

2. Three of the late-loss ADLs indicate total dependence on the prior assessment, as in #1 AND the fourth late-loss ADL indicates extensive assistance

value 3) on the prior assessment.

(

3. If resident is comatose (B0100 = [1, -]) on the target assessment.

4. Prognosis of life expectancy is less than 6 months (J1400 = [1, -]) on the target assessment.

5. Hospice care (O0100K2 = [1, -]) on the target assessment.

6. The resident is not in the numerator and

6.1. Bed Mobility (G0110A1 = [-]) on the prior or target assessment, or

6.2. Transferring (G0110B1 = [-]) on the prior or target assessment, or

6.3. Eating (G0110H1) = [-]) on the prior or target assessment, or

6.4. Toileting (G0110I1 = [-]) on the prior or target assessment.

Not applicable.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 48

Covariates

Page 53

Table 2-27

Percent of Residents Who Lose Too Much Weight (LS)

(CMS ID: N029.02) (NQF #0689)

Measure Description

The measure captures the percentage of long-stay residents who had a weight loss of 5% or more in the last month or 10% or more in the last 6 months who were not on a physician prescribed weight-loss regimen noted in an MDS assessment during the selected quarter.

Measure Specifications

Numerator

Long-stay nursing home residents with a selected target assessment which indicates a weight loss of 5% or more in the last month or 10% or more in the last 6

onths who were not on a physician prescribed weight-loss regimen (K0300 = [2]).

Denominator

Long-stay nursing home residents with a selected target assessment except those with exclusions.

Exclusions

1. Target assessment is an OBRA Admission assessment (A0310A= [01]) or a PPS 5-Day assessment (A0310B= [01])

2. Prognosis of life expectancy is less than 6 months (J1400 = [1]) or the Prognosis item is missing (J1400 = [-]) on the target assessment.

3. Receiving Hospice care (O0100K2 = [1]) or the Hospice care item is missing (O0100K2 = [-]) on the target assessment.

4. Weight loss item is missing (K0300= [-]) on the target assessment.

Not applicable.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 49

Covariates

Page 54

Table 2-28

Percent of Residents Who Have Depressive Symptoms (LS)

(CMS ID: N030.02) (NQF #0690 – Withdrawn)

Measure Description

The measure reports the percentage of long-stay residents who have had symptoms of depression during the 2-week period preceding the MDS 3.0 target assessment date.

Measure Specifications

Numerator

Long-stay residents with a selected target assessment where the target assessment meets either of the following two conditions:

CONDITION A (The resident mood interview must meet Part 1 and Part 2 below)

PART 1:

• Little interest or pleasure in doing things half or more of the days over the last two weeks (D0200A2 = [2, 3]).

• Feeling down, depressed, or hopeless half or more of the days over the last two weeks (D0200B2 = [2, 3]).

PART 2:

The resident interview total severity score indicates the presence of depression (D0300 ≥ [10] and D0300 ≤ [27]).

CONDITION B: (The staff assessment of resident mood must meet Part 1 and Part 2 below)

PART 1:

• Little interest or pleasure in doing things half or more of the days over the last two weeks (D0500A2 = [2, 3]).

• Feeling or appearing down, depressed, or hopeless half or more of the days over the last two weeks (D0500B2 = [2, 3]).

PART 2:

The staff assessment total severity score indicates the presence of depression (D0600 ≥ [10] and D0600 ≤ [30]).

Denominator

All long-stay residents with a selected target assessment, except those with exclusions.

Exclusions

1. Resident is comatose or comatose status is missing (B0100 = [1, -]).

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 50

Page 55

Measure Specifications Continued

2. Resident is not included in the numerator (the resident did not meet the depression symptom conditions for the numerator) AND both of the following

are true:

2.1. D0200A2 = [^, -] or D0200B2 = [^, -] or D0300 = [99, ^, -].

2.2. D0500A2 = [^, -] or D0500B2 = [^, -] or D0600 = [^, -].

Covariates

Not applicable.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 51

Page 56

Table 2-29

Percent of Residents Who Received an Antipsychotic Medication (LS)21

(CMS ID: N031.03) (NQF: None)

Measure Description

This measure reports the percentage of long-stay residents who are receiving antipsychotic drugs in the target period.

Measure Specifications

Numerator

Long-stay residents with a selected target assessment where the following condition is true: antipsychotic medications received. This condition is defined as

llows:

1. For assessments with target dates on or after 04/01/2012: (N0410A = [1, 2, 3, 4, 5, 6, 7]).

Denominator

Long-stay nursing home residents with a selected target assessment except those with exclusions.

Exclusions

1. The resident did not qualify for the numerator and any of the following is true:

1.1. For assessments with target dates on or after 04/01/2012: (N0410A = [-]).

2. Any of the following related conditions are present on the target assessment (unless otherwise indicated):

2.1. Schizophrenia (I6000 = [1]).

2.2. Tourette’s syndrome (I5350 = [1]).

2.3. Tourette’s syndrome (I5350 = [1]) on the prior assessment if this item is not active on the target assessment and if a prior assessment is

lable.

avai

2.4. Huntington’s disease (I5250 = [1]).

Not applicable.

This measure is used in the Five-Star Quality Rating System.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 52

Covariates

Page 57

Table 2-30

Prevalence of Falls (LS)22

(CMS ID: N032.02) (NQF#: None)

Measure Description

This measure reports the percentage of long-stay residents who have had a fall during their episode of care.

Measure Specifications

Numerator

Long-stay residents with one or more look-back assessments that indicate the occurrence of a fall (J1800 = [1]).

Denominator

All long-stay nursing home residents with one or more look-back scan assessments except those with exclusions.

Exclusions

Resident is excluded if the following is true for all of the look-back scan assessments:

1. The occurrence of falls was not assessed (J1800 = [-]).

Covariates

Not applicable.

This measure is not reported on NHC and is only available on the CASPER QM reports

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 53

Page 58

Tabel 2-31

Prevalence of Antianxiety/Hypnotic Use (LS)23

(CMS ID: N033.02) (NQF#: None)

Measure Description

This measure reports the percentage of long-stay residents who are receiving antianxiety medications or hypnotics but do not have evidence of psychotic or related conditions in the target period.

Measure Specifications

Numerator

Long-stay residents with a selected target assessment where any of the following conditions are true:

1. For assessments with target dates on or after 04/01/2012:

1.1. Antianxiety medications received (N0410B = [1, 2, 3, 4, 5, 6, 7]), or

1.2. Hypnotic medications received (N0410D = [1, 2, 3, 4, 5, 6, 7]).

Denominator

All long-stay residents with a selected target assessment, except those with exclusions.

Exclusions

1. The resident did not qualify for the numerator and any of the following is true:

1. For assessments with target date on or after 04/01/2012: N0410B = [-] or N0410D = [-].

2. Any of the following related conditions are present on the target assessment (unless otherwise indicated):

1. Schizophrenia (I6000 = [1]).

2. Psychotic disorder (I5950 = [1]).

3. Manic depression (bipolar disease) (I5900 = [1]).

4. Tourette’s syndrome (I5350 = [1]).

5. Tourette’s syndrome (I5350 = [1]) on the prior assessment if this item is not active on the target assessment and if a prior assessment is

avai

lable.

6. Huntington’s disease (I5250 = [1]).

7. Hallucinations (E0100A = [1]).

This measure is not reported on NHC and is only available on the CASPER QM reports.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 54

Page 59

8. Delusions (E0100B = [1]).

9. Anxiety disorder (I5700 = [1]).

10. Post-traumatic stress disorder (I6100 = [1]).

11. Post-traumatic stress disorder (I6100 = [1]) on the prior assessment if this item is not active on the target assessment and if a prior assessment

available.

Not applicable.

Measure Specifications Continued

Covariates

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 55

Page 60

Table 2-32

Prevalence of Behavior Symptoms Affecting Others (LS)24

(CMS ID: N034.02) (NQF#: None)

Measure Description

This measure reports the percentage of long-stay residents who have behavior symptoms that affect others during the target period.

Measure Specifications

Numerator

Long-stay residents with a selected target assessment where any of the following conditions are true:

1. The presence of physical behavioral symptoms directed towards others (E0200A = [1, 2, 3]), or

2. The presence of verbal behavioral symptoms directed towards others (E0200B = [1, 2, 3]), or

3. The presence of other behavioral symptoms not directed towards others (E0200C = [1, 2, 3]), or

4. Rejection of care (E0800 = [1, 2, 3]), or

5. Wandering (E0900 = [1, 2, 3]).

Denominator

All residents with a selected target assessment, except those with exclusions.

Exclusions

Resident is not in numerator and any of the following is true:

1. The target assessment is a discharge (A0310F = [10, 11].

2. E0200A is equal to [-, ^].

3. E0200B is equal to [-, ^].

4. E0200C is equal to [-, ^].

5. E0800 is equal to [-, ^].

6. E0900 is equal to [-, ^].

Covariates

Not applicable.

This measure is not reported on NHC and is only available on the CASPER QM reports.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 56

Page 61

Table 2-33

Percent of Residents Whose Ability to Move Independently Worsened (LS)25

(CMS ID: N035.03) (NQF: None)

Measure Description

This measure reports the percent of long-stay residents who experienced a decline in independence of locomotion during the target period.

Measure Specifications

Numerator

Long-stay residents with a selected target assessment and at least one qualifying prior assessment who have a decline in locomotion when comparing their

get assessment with the prior assessment. Decline identified by:

tar

1. Recoding all values (G0110E1 = [7, 8]) to (G0110E1 = [4]).

2. An increase of one or more points on the “locomotion on unit: self-performance” item between the target assessment and prior assessment (G0110E1

target assessment – G0110E1 on prior assessment ≥1).

Denominator

Long-stay residents who have a qualifying MDS 3.0 target assessment and at least one qualifying prior assessment, except those with exclusions.

Exclusions

esidents satisfying any of the following conditions:

1. Comatose or missing data on comatose (B0100 = [1, -]) at the prior assessment.

2. Prognosis of less than 6 months at the prior assessment as indicated by:

2.1. Prognosis of less than six months of life (J1400 = [1]), or

2.2. Hospice use (O0100K2 = [1]), or

2.3. Neither indicator for being end-of-life at the prior assessment (J1400 ≠ [1] and O0100K2 ≠ [1]) and a missing value on either indicator (J1400 =

[-] or O

3. Resident totally dependent during locomotion on prior assessment (G0110E1 = [4, 7, or 8]).

4. Missing data on locomotion on target or prior assessment (G0110E1 = [-]).

5. Prior assessment is a discharge with or without return anticipated (A0310F = [10, 11]).

6. No prior assessment is available to assess prior function.

0100K2 = [-]).

This measure is used in the Five-Star Quality Rating System.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 57

Page 62

6.1. Target assessment is an OBRA Admission assessment (A0310A = [01]), a PPS 5-Day assessment (A0310B = [01]), or the first assessment after

an admission (A0310E = [1]).

Covariates used to risk-adjust this measure include:

1. Eating (self-performance) from prior assessment

1.1 Needs Help Covariate = 1 if (G0110H1 = [2, 3]) and Covariate = 0 if (G0110H1 = [-, 0, 1, 4, 7, 8]).

1.2 Dependence Covariate = 1 if (G0110H1 = [4,7,8)] and Covariate = 0 if (G0110H1 = [-, 0,1,2,3]).

2. Toileting (self-performance) from prior assessment

2.1 Needs Help Covariate = 1 if (G0110I1 = [2, 3]) and Covariate = 0 if (G0110I1 = [-, 0, 1, 4, 7, 8]).

2.2 Dependence Covariate = 1 if (G0110I1 = [4,7,8]) and Covariate = 0 if (G0110I1 = [-, 0,1,2,3]).

3. Transfer (self-performance) from prior assessment

3.1 Needs Help Covariate = 1 if (G0110B1 = [2,3]) and Covariate = 0 if (G0110B1 = [-, 0, 1, 4, 7, 8]).

3.2 Dependence Covariate = 1 if (G0110B1 = [4,7,8]) and Covariate = 0 if (G0110B1 = [-, 0,1,2,3]).

4. Walking in Corridor (self-performance) from prior assessment

4.1 Independence Covariate = 1 if (G0110D1 = [0,1]) and Covariate = 0 if (G0110D1 = [-, 2, 3, 4, 7, 8]).

4.2 Needs Some Help Covariate = 1 if (G0110D1 = [2]) and Covariate = 0 if (G0110D1 = [-, 0, 1, 3, 4, 7, 8]).

4.3 Needs More Help Covariate = 1 if (G0110D1 = [3]) and Covariate = 0 if (G0110D1 = [-, 0, 1, 2, 4, 7, 8]).

5. Severe cognitive impairment from prior assessment

5.1 Covariate = 1 if (C1000 = [3] and C0700 = [1]) or BIMS summary score (C0500 ≤ [7]).

Covariate = 0 if (C1000 = [0, 1, 2, ^, -] or C0700 = [0, ^, -]) and (C0500 = [>7, ^, -, 99])

If Covariate has not been set to 1 or 0 based on logic in 5.1 and 5.2, then Covariate = [0].

6. Linear Age

If (MONTH(A2300) > MONTH(A0900)) or(MONTH(A2300) = MONTH(A0900) and

DAY(

A2300) >= DAY(A0900)) then Linear Age = YEAR(A2300)-YEAR(A0900) else Linear Age = YEAR(A2300)-YEAR(A0900)-1

7. Gender

7.1 Covariate = 1 if (A0800= [2]) (Female).

Covariate = 0 if (A0800= [1]) (Male).

8. Vision

8.1 Covariate = 1 if B1000 change score >0 with change score calculated from B1000 on the prior assessment to B1000 on the latest assessment with

n-missing after the prior assessment.

Covariate = 0 if either of the following criteria are met:

Measure Specifications Continued

Covariates

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 58

Page 63

• B1000 change score ≤ 0 with change score calculated from B1000 on the prior assessment to B1000 on the latest assessment with non-

missing B1000 after prior assessment.

• B1000 is not missing on the prior assessment, B1000 is missing on the target assessment, and no intermediate assessment has a non-missing

alue for B1000.

If Covariate has not been set to 1 or 0 based on logic in 8.1 and 8.2, then Covariate = [0].

9. Oxygen use

9.1 Covariate = 1 where (O0100C2 = [0]) on prior and (O0100C2 = [1]) on the latest assessment with non-missing O0100C2 after prior assessment.

Covariate = 0 if (O0100C2 = [0]) on the latest assessment with non missing O0100C2 after prior assessment or

• O0100C2 is not missing on the prior assessment, O0100C2 is missing on the target assessment, and no intermediate assessment has a non-

issing value for O0100C2.

If Covariate has not been set to 1 or 0 based on logic in 9.1, then Covariate = [0].

10. All covariates are missing if no prior assessment is available.

Covariates Continued

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 59

Page 64

Table 2-34

Percent of Residents Who Used Antianxiety or Hypnotic Medication (LS)

(CMS ID: N036.02) (NQF: None)

Measure Description

This measure reports the prevalence of antianxiety or hypnotic medication use (long stay) during the target period.

Measure Specifications

Numerator

Long-stay residents with a selected target assessment where any of the following conditions are true:

1. For assessments with target dates on or after 04/01/2012:

1.1 Antianxiety medications received (N0410B = [1, 2, 3, 4, 5, 6, 7]), or

1.2 Hypnotic medications received (N0410D = [1, 2, 3, 4, 5, 6, 7]).

Denominator

Long-stay residents with a selected target assessment, except those with exclusions.

Exclusions

1. The resident did not qualify for the numerator and any of the following is true:

1.1. For assessments with target dates on or after 04/01/2012: (N0410B = [-] or N0410D = [-]).

2. Any of the following related conditions are present on the target assessment (unless otherwise indicated):

2.1. Life expectancy of less than 6 months (J1400 = [1]).

2.2. Hospice care while a resident (O0100K2 = [1]).

Covariates

Not applicable.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 60

Page 65

Chapter 3

Technical Details

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 61

Page 66

Quality Measures (QM) Technical Details

List of Contents:

Section 1 Introduction ............................................................................................63

Section 2 Steps Used In National QM Calculation ................................................65

Section 3 Calculation of the Expected QM Score .................................................69

Section 4 Calculation of the Adjusted QM Score ..................................................72

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 62

Page 67

Section 1

Introduction

This chapter presents technical details regarding the calculation of the nursing home quality measures (QMs), including the methodology used for risk adjustment.

Overview of QM Calculations

The QMs are created from counts of nursing facility long stay residents or short stay residents who have certain conditions or problems (e.g., falls resulting in major injury). For example, facility-level scores for the long stay falls QM are computed by: 1) counting residents in the facility who had a fall resulting in major injury and 2) computing the percent of residents in the facility who had valid MDS data and who experienced such a fall. The detailed logic for defining the resident-level outcomes for each QM is presented in the QM Sample and Record Selection Methodology section and in the Quality Measure Logic Specifications section of this manual. This logic is listed under the "Numerator" entry for each QM.

A Note on Risk Adjustment

Risk adjustment refines raw QM scores to better reflect the prevalence of problems that facilities should be able to address. Two complementary approaches to risk adjustment are applied to the QMs.

One approach involves exclusion of residents whose outcomes are not under nursing facility control (e.g., outcome is evidenced on admission to the facility) or the outcome may be unavoidable (e.g., the resident has end-stage disease or is comatose). All of the QMs, except the vaccination QMs, are shaped by one or more exclusions. For each QM, the prevalence of the outcome across all residents in a nursing facility, after exclusions, is the facility-level observed QM score.

A second approach involves adjusting QM scores directly, using logistic regression. This method of adjustment employs resident-level covariates that are found to increase the risks of an outcome. Detailed specifications for resident-level covariates are presented in the Quality Measure Logical Specifications section of this manual. This approach involves the following steps:

• First, resident-level covariates were used in a logistic regression model to calculate a

resident-level expected QM score (the probability that the resident will evidence the outcome, given the presence or absence of characteristics measured by the covariates). Section 3 of this Appendix presents the details for calculating expected scores for residents.

• Then, an average of all resident-level expected QM scores for the nursing facility was

calculated to create a facility-level expected QM score.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 63

Page 68

• The final facility-level adjusted QM score was based on a calculation which combines the

facility-level expected score and the facility-level observed score. The details for

calculating facility-level adjusted scores are presented in Section 4 of this Appendix. The parameters used for each release of the QMs are presented in Appendix B.

Only four of the QMs are adjusted using resident level covariates for public reporting:

• S038.02: Changes in Skin Integrity Post-Acute Care: Pressure Ulcer/Injury

• N037.03: Percent of Residents Who Improved Performance on Transfer, Locomotion,

and Walking in the Corridor (Short Stay)

• N026.03: Percent of Residents Who Have/Had a Catheter Inserted and Left in Their

Bladder (Long Stay)

• N035.03: Percent of Residents Who Declined in Independence in Locomotion (Long

Stay)

The remaining QMs are not adjusted using resident-level covariates. For these measures, facility-level observed QM scores are reported.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 64

Page 69

Section 2

Steps Used in National QM Calculation

Introduction

This section outlines the processing steps used to calculate QMs. The description below uses Q1 2019 as the target period. The dates associated with these steps would be updated, as appropriate, for subsequent quarterly releases of the QMs. It is important to note two items that recurred throughout the process:

Every step in file construction and QM calculation proceeded in parallel for two samples of residents and facilities: a “Long stay” (LS) sample and a “Short stay” (SS) sample.

• Two “target periods” were defined:

– a “Current Period” which was one quarter, Q1 2019, for LS residents and two

quarters, Q4 2018 and Q1 2019, for SS patients. Data from the current periods were used as the target period for final QM reporting;

– a “Current Year”, Q2 2018 through Q1 2019, of data were used to estimate logistic

regressions for risk adjustment.

Processing Steps:

1. MDS Selection. All MDS records for U.S. nursing facilities in Q2 2018 through Q1 2019

were selected.

2. Episode Creation. Using the definitions contained elsewhere in this document, episodes

were created from the available data. Each episode, which may include one or more interruptions, indicated by Interrupted Stay (A0310G1 = [1]), was classified as either long or short stay depending upon the number of cumulative days in the facility. Only the latest episode was retained for each resident.

3. Sampling for LS QMs. Nursing facilities and residents were sampled to provide data for LS

QM and covariate calculations.

a. “Current Period” LS resident sample: residents were included in this sample if they

had a long stay episode that ended within the last quarter of the target period (i.e., Q1

2019).

b. “Current Year” LS resident sample: residents were included in this sample if they had

a long stay episode in the target period (Q2 2018 through Q1 2019).

c. “Influenza Season” LS resident sample: includes residents with an influenza

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 65

Page 70

QMs, which occurs after the most recent influenza season has been completed (i.e., after the end of June).

4. Sampling for SS QMs. Nursing facilities and residents were sampled to provide data for SS

QM and covariate calculations.

a. “Current Period” SS resident sample: residents were included in this sample if they

had a short stay episode that ended within the last two quarters of the target period (i.e., Q4 2018 and Q1 2019).

b. “Current Year” SS resident sample: residents were included in this sample if they had

a short stay episode in the target period (Q2 2018 through Q1 2019).

c. “Influenza Season” SS resident sample: includes residents with an influenza

vaccination target assessment for the most recently completed influenza season, which begins on July 1 of a given year and ends on June 30 of the subsequent year. Only sampled once a year for the annual calculation of the influenza vaccination QMs, which occurs after the most recent influenza season has been completed (i.e., after the end of June).

5. Resident-level QM Calculation Files. At this point, resident-level QM calculation files were

created, separately for each LS resident sample and each SS resident sample, using the specified target, prior, initial, and influenza vaccination assessments for each resident record as appropriate.

6. Resident-level QM and Covariate Calculation Files. Next, resident-level QM scores were

calculated (and covariate values were calculated for the risk-adjusted QMs), separately for each LS resident and SS resident.

a. Resident-level QM calculation (all QMs):

i. Resident exclusions: For each QM, excluded residents were assigned a missing

value for that QM. Residents with missing covariate values were also assigned a missing value for that QM.

ii. QM values: does the resident “trigger” the QM?

1. If “Yes”, then store a value of 1 for that QM in the resident-level QM

calculation record appropriate to that resident for a sample.

2. If “No”, then store a value of 0 for that QM in the resident-level QM

calculation record appropriate to that resident for a sample.

b. Resident-level covariate calculation (risk-adjusted QMs):

i. Resident exclusions: For each QM, excluded residents were assigned a missing

value for that QM. Residents with missing covariate values were also assigned a missing value for that QM.

ii. Covariate: does the resident “trigger” the covariate?

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 66

Page 71

1. If “Yes”, then store a value of 1 for that covariate in the resident-level QM

calculation record appropriate to that resident for a sample.

2. If “No”, then store a value of 0 for that covariate in the resident-level QM

calculation record appropriate to that resident for a sample.

7. Logistic Regressions. With the resident-level files complete, and all relevant exclusions

applied, logistic regressions for the risk-adjusted QMs were estimated using the Current Year LS and SS samples (Q2 2018 through Q1 2019).

a. Input: LS or SS resident-level file.

b. Dependent variable: was the QM triggered? (yes = 1, no = 0).

c. Predictors: resident-level covariates.

d. Calculation of logistic regressions: (See Section 3 in this Appendix).

e. Output values: logistic regression constant term and resident-level covariate

coefficients for each of the risk-adjusted QMs. The resulting values are given in Table B.1 of Appendix B.

The logistic regression results calculated for Q1 2019 will remain in effect for QM calculation in subsequent quarters. Recalculation may occur sometime in the future if deemed appropriate.

8. Resident-level Expected QM Scores. For the QMs that were risk adjusted, resident-level

expected QM scores were calculated for each resident for the Current Period LS and SS samples. (See Section 3 in this Appendix for calculation formulas).

a. Input: logistic regression constant term and resident-level covariate coefficients from

the previous step for each adjusted QM.

b. Output values: resident-level expected QM scores for each resident, for each of the

risk-adjusted QMs.

9. National Mean QMs. National mean observed QMs were needed for calculating the facility-

level adjusted QM scores below. The overall national mean observed QM scores for the Current Period LS and SS samples were calculated, for each risk adjusted QM:

a. Numerator: for each QM, count the total number or residents that triggered the QM

and sum for the nation.

b. Denominator: for each QM, count the total number of residents retained after

exclusions and sum for the nation. Note that the sample will include only those residents with non-missing data for the component covariates.

c. Overall national mean observed QM score: divide the numerator by the denominator.

10. Facility-level Observed QM Scores. For all QMs, the facility-level observed QM scores were

calculated for the Current Period LS and SS samples -- for the QMs that were not risk adjusted, these are the measures that will be publicly reported.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 67

Page 72

a. Numerator: for each QM, count the total number of residents who triggered the QM

in each facility and sum for the nursing facility.

b. Denominator: for each QM, count the total number of residents retained after

exclusions for each facility and sum for the nursing facility. Note that the sample will include only those residents with non-missing data for the component covariates.

c. Facility-level observed QM scores: divide the numerator by the denominator for each

QM and nursing facility.

11. Facility-level Expected QM Scores. For the risk-adjusted QMs, the facility-level expected

QM scores are calculated for the Current Period LS and SS samples. This is done by averaging the resident-level expected QM scores for each QM within each nursing facility. Note that the sample will include only those residents with non-missing data for the component covariates.

12. Facility-level Adjusted QM Scores. Finally, for the risk-adjusted QMs, the facility-level

adjusted QM scores were calculated for the Current Period LS and SS samples.

a. Input -- for each of the risk-adjusted QMs

i. Facility-level observed QM scores

ii. Facility-level expected QM scores

iii. National mean observed QM scores

b. Calculation: (See Section 4 of this Appendix for calculation formulas)

c. Output: Facility-level adjusted QM scores for the five risk-adjusted QMs

13. Final Facility-level Output File. The final facility-level output files for the Current Period

LS and SS QMs contained the following:

a. For all QMs:

i. Facility numerator counts

ii. Facility denominator counts

iii. Facility-level observed QM scores (publicly reported for the unadjusted QMs)

b. For the risk-adjusted QMs: Facility-level adjusted QM scores (publicly reported

scores)

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 68

Page 73

Section 3

Calculation of the Expected QM Score

For the QMs adjusted with resident-level covariates, the resident-level expected QM score was calculated as an intermediate step to obtaining an adjusted QM score for the facility. This section describes the technical details referred to in Section 2 of this chapter.

Calculating Resident-level Expected QM Scores

The resident-level expected score for a QM is an estimate of the risk that a resident will trigger the QM. This estimate is based on consideration of the resident-level covariates associated with the QM.

For each of the risk-adjusted QMs, a resident-level logistic regression was estimated. Data came from the short stay and long stay samples described in the prior section of this appendix. The resident-level observed QM score was the dependent variable. The predictor variables were one or more resident-level covariates associated with the QM. Calculation of the QM and covariate scores is described in Section 2 (Step 5) of this Appendix.

Each logistic regression had the following form:

[1]

QM triggered (yes = 1; no = 0)= B

+ B

∗COV

+ B

∗COV

+ ⋯+ B

∗COV

where B0 is the logistic regression constant, B1 is the logistic regression coefficient for the first covariate, COVA is the resident-level score for the first covariate, B2 is the logistic regression coefficient for the second covariate (where applicable), and COVB is the resident-level score for the second covariate (where applicable), and so on.

Each resident’s expected QM score could then be calculated with the following formula:

[2] Resident-level expected QM Score =

[1 + e

−X

]

where e is the base of natural logarithms and x is a linear combination of the constant and the logistic regression coefficients times the covariate scores (from Formula [1], above). A covariate

score will be 1 if the covariate is triggered for that resident, and 0 if not

As an example, consider the actual calculation used for the expected score for the LS "Percent of re

sidents who have/had a catheter inserted and left in their bladder" QM (N026.03). The covariates for that QM are indicators of bowel incontinence and pressure ulcers at stages II – IV on the prior assessment. The equation used for this QM (with the parameters from Table B.1 for Q1 2018) is:

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 69

Page 74

[3] N026.03 =

(

−

[1 + e

where B0 is the logistic regression constant, B1 is the logistic regression coefficient for BowInc, the resident-level covariate indicating bowel incontinence, and B2 is the logistic regression coefficient for PresUlcer, the resident-level covariate indicating pressure ulcers at stages II – IV.

The N026.03 score for a resident who triggers the bowel incontinence and pressure ulcers at stages II – IV covariates (covariate scores = 1) is expected to be:

B0+B

∗BowInc +B2∗PresUlcer

[4] 0.1747 =

[1 + e

−(−4.281009+0.4587008 ∗1+2.26932 ∗1)

)

]

For a resident who does not trigger the bowel incontinence or pressure ulcers at stages II – IV covariates (covariate scores = 0), the N026.03 score is expected to be:

[5] 0.0136 =

[1 + e

Thus, a resident who is bowel incontinent and has pressure ulcers at stages II – IV (i.e. covariates = 1) is over twelve times as likely to report having a catheter inserted and left in their bladder (17.47 percent) compared to a resident who is not bowel incontinent and does not have pressure ulcers at stages II – IV (1.36 percent).

For a resident who triggers only the bowel incontinence covariate (covariate score = 1) and not the pressure ulcers at stages II – IV covariate (covariate score = 0), the N026.03 score is expected to be:

−(−4.281009+0.4587008 ∗0+2.26932 ∗0)

[6] 0.0214 =

]

[1 + e

−(−4.281009+0.4587008 ∗1+2.26932∗0)

For a resident who does not trigger the bowel incontinence covariate (covariate score = 0) and triggers only the pressure ulcers at stages II – IV covariate (covariate score = 1), the N026.03 score is expected to be:

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 70

Page 75

[7] 0.1180 =

[1 + e

Thus, a resident who has pressure ulcers at stages II – IV (i.e. covariates = 1) is over five times as likely to report having a catheter inserted and left in their bladder (11.80 percent) compared to a resident who is bowel incontinent (2.14 percent). The parameters used for calculating the resident-level expected QM scores are presented in Table B.1 of Appendix B.

Calculating Facility-level Expected QM Scores

Once an expected QM score has been calculated for all residents at risk, the facility-level expected QM score is simply the average of all resident-level scores for each of the risk-adjusted QMs.

−(−4.281009+0.4587008 ∗0+2.26932 ∗1)

]

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 71

Page 76

Section 4

Calculation of the Adjusted QM Score

The risk-adjusted QM score is a facility-level QM score adjusted for the specific risk for that QM in the nursing facility. The risk-adjusted QM score can be thought of as an estimate of what the nursing facility's QM rate would be if the facility had residents with average risk.

The facility-level adjusted score is calculated using the following scores:

• The facility-level observed QM score,

• The facility-level average expected QM score, and

• The national average observed QM score.

The actual calculation of the adjusted score uses the following equation:

[8] Adj =

[1 + e

−y

]

where

Adj is the facility-level adjusted QM score, and

Obs

y = (Ln (

)−Ln (

1 −Obs

Obs is the facility-level observed QM rate,

Exp

)+ Ln (

1 −Exp

Nat

))

1 −Nat

Exp is the facility-level expected QM rate, Nat is the national observed QM rate, and Ln indicates a natural logarithm.

e is the base of natural logarithms

Note that the adjusted QM rate (Adj) is calculated differently in two special cases:

1. When Obs equals 0.00, then Adj is set to 0.00 (without using the equation).

2. When Obs equals 1.00, then Adj is set to 1.00 (without using the equation).

The adjusted QM score equation will produce adjusted scores in the range of 0 to 1. These adjusted scores can then be converted to percentages for ease of interpretation.

These adjusted score calculations are applied to QMs that use expected scores based on residentlevel covariates (See Section 3 of this Appendix). The national average observed QM rates, required for these calculations, are presented in Appendix B.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 72

Page 77

Parameters Used for Each Quarter

Chapter 4

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 73

Page 78

N o

Introduction

This chapter presents the model parameters that were estimated for the risk adjusted QMs for the following time period:

• The period ending March 31, 2018 referred to as Q1 2018.

The purpose of this document is to present the logistic regression coefficients used in the risk adjustment calculations that were applied to the risk-adjusted QMs. For details regarding the use of these parameters, please refer to Chapter 3.

Logistic Regression Coefficients

Five QMs are risk adjusted. The logistic regression coefficients used are presented in Table 4-1. Where risk adjustment involves the use of more than one resident-level covariate, coefficients are listed in the order presented in the LS and SS matrices that are presented in the MDS 3.0 Quality Measures Logical Specifications section of this manual. The calculations in Table 4-1 are based on calculations for the Current Year sample ending with Q1 2018.

Table 4-1. Logistic Regression Coefficients

QM Constant (Intercept) Resident-Level Covariates

S038.02

N037.03 0.7823972

For the Constant and Resident-Level Covariates, please refer to the latest

ersion of the Risk Adjustment Appendix File for CMS ID: S038.02 in the

v SNF Measure Calculations and Reporting User’s Manual, found at the following URL:

ssessment-Instruments/NursingHomeQualityInits/Skilled-Nursing-FacilityQuality-Reporting-Program/SNF-Quality-Reporting-Program-Measures-andTechnical-Information.html

https://www.cms.gov/Medicare/Quality-Initiatives-Patient-

1. Covariate 1.1 (Age Category≤54)

2. Covariate 1.2 (Age Category 54 to

84)

(reference category)

3. Covariate 1.3 (Age Category>84) -0.16045

4. Covariate 2.1 (Female) 0.0272314

5. Covariate 3.1 (Cognitive Impairment)

6. Covariate 4.1 (ADL Lowest Tercile)

7. Covariate 4.2 (ADL Middle Tercile)

reference category)

(

8. Covariate 4.3 (ADL Highest Tercile) -0.2748568

9. Covariate 5.1 (Heart Failure) -0.0636875

10. Covariate 6.1 (CVA/TIA/Stroke) -0.1366926

No data

d a t a

-0.053567

0.0

-0.5714708

-0.161358

0.0

d a t a

11. Covariate 7.1 (Hip Fracture) 0.2954314

12. Covariate 8.1 (Other Fracture) 0.233453

N026.03 -4.281009

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 74

1. Covariate 1.1 (Bowel Incontinence) 0.4587008

2. Covariate 2.1 (Pressure Ulcer) 2.26932

Page 79

Table 4-1. Logistic Regression Coefficients (continued)

QM Constant (Intercept) Resident-Level Covariates No data

N035.03 -2.469571

1. Covariate 1.1 (Help with Eating) 0.0095926

2. Covariate 1.2 (Dependence Eating)

3. Covariate 2.1 (Help with Toileting)

4. Covariate 2.2 (Dependence Toileting)

5. Covariate 3.1 (Help with Transfer)

6. Covariate 3.2 (Dependence with Transfer)

7. Covariate 4.1 (Independence with Walking)

8. Covariate 4.2 (Some Help with Walking)

9. Covariate 4.3 (More Help with Walking)

10. Covariate 5 (Severe Cognitive Impairment)

11. Covariate 6 (Age) 0.008044

0.5191111

0.2583423

0.4434241

0.0760023

0.4310152

0.0428471

-0.1233525

-0.6388195

0.1311536

12. Covariate 7 (Female) 0.0277615

13. Covariate 8 (Impaired Vision) 0.3495715

14. Covariate 9 (Oxygen Use) 0.8450993

National Observed Means

The national observed QM means are updated for each quarterly release. Table 4-2 presents these means for Q1 2018, as an example.

Table 4-2. National Observed QM Means

QM Q1 2018

S038.02

N037.03 0.6458298

N026.03 0.0227849

N035.03 0.1854863

Please refer to the latest version of the Risk Adjustment Appendix File for CMS ID: S038.02 in the SNF Measure

Calculations and Reporting User’s Manual found at the following URL: https://www.cms.gov/Medicare/Quality-

Initiatives-Patient-Assessment-Instruments/NursingHomeQualityInits/Skilled-Nursing-Facility-QualityReporting-Program/SNF-Quality-Reporting-Program-Measures-and-Technical-Information.html

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 75

Page 80

Episode and Stay Determination Logic

Chapter 5

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 76

Page 81

MDS 3.0 Episode and Stay Determination

Logic

Introduction

Several CMS applications are based upon the identification of stays and episodes using MDS 3.0 data. This chapter provides definitions and detailed logic that can be used by these applications.

This chapter begins with definitions of key terms and concepts. It then explains how stays and episodes are identified in a well-defined assessment data stream (i.e., when all assessment completion and submission rules are followed). It concludes with detailed logic that handles exceptional cases (e.g., missing entry or discharge records).

Definitions

An episode consists of one or more stays, and a stay is the period of time between a resident’s entry into a facility and either (a) a discharge, or (b) the end of the target period, whichever comes first. A stay may include one or more interruptions lasting 3 calendar days or less. Because an episode is built from a set of one or more stays, the episode can be identified if the stays have been built properly. Therefore, this section will describe how to build stays.

Three properties of each stay must be determined:

• The starting date.

• The ending date.

• The stay type (admission or reentry).

The starting date is the date the resident entered the facility (either for the first time or after a previous discharge). The ending date is either (a) the discharge date, or (b) the end of the target period, whichever is earlier. The stay type is defined as follows:

Admission. An admission occurs when any one of the following conditions apply:

• The resident has never been admitted to this facility before; or

• The resident has been in this facility previously and was discharged return not

anticipated; or

• The resident has been in this facility previously and was discharged return anticipated

and did not return within 30 days of discharge.

Reentry. A reentry occurs when both of the following conditions apply:

• The resident has a discharge return anticipated, and

• The resident returned to the facility within 30 days of discharge.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 77

Page 82

Rules for a Well- Constructed Data Stream

In a well-constructed data stream (where all records are submitted and correctly coded), the following logic will correctly determine the starting date, ending date, and type for each stay. This logic assumes that the resident’s records have been sorted in reverse chronological order (see the end of this section for sorting details). Stays and episodes must be contained within a single facility, so the following logic applies to the records for a single facility.

1. If the first (latest) record that is on or before the end of the reporting period is a discharge

(A0310F = [10, 11, 12]), then the stay end date is equal to the discharge date (A2000). Otherwise, the stay is ongoing and the stay end date is equal to the end of the reporting period.

2. If the stay end date of the resident’s latest stay chronologically precedes the beginning of

the target period27, then the episode is not included in the sample. If the stay is ongoing or if the discharge occurs within the target period, then continue.

3. Scan backwards chronologically until an entry record (A0310F = [01]) is encountered.

The stay start date is equal to the entry date (A1600) on the entry record.

4. Look at the chronologically preceding record. The stay type is defined as follows:

4.1. If a chronologically preceding record is found and if it is a discharge return

anticipated (A0310F = [11]) and if the discharge date of the discharge record is within 30 days of the stay start date defined above, then the stay type is a reentry. Otherwise, the stay type is an admission. Admissions occur under any of the following conditions:

4.1.1. No chronologically preceding record is found.

4.1.2. A chronologically preceding record is found and it is a discharge return not

anticipated (A0310F = 10).

4.1.3. A chronologically preceding record is found and it is a discharge return

anticipated (A0310F = 11) and the discharge date is 31 days or more before the stay start date.

5. If the stay was classified as an admission stay, then scanning would stop because this

would mark the beginning of the episode. If the stay was a reentry, then the scan logic would continue with the stay that ended with the record found in Step #4 (if any). Stays would continue to be scanned and classified until one of the following conditions occurred:

The span of time that defines the application’s reporting period (e.g., a calendar quarter).

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 78

Page 83

5.1. An admission stay was identified, or

5.2. No more records were found for the same resident and facility, or

5.3. An application-specific rule was met. For example, for short stay Quality Measures

(QMs), processing stops when the number of cumulative days in the facility (CDIF) exceeded 100 days (CDIF is the sum of the number of days within each of the stays that are contained in the episode).

Handling Missing Records

Exceptions to the rules will occur when entry and/or discharge records are missing from a resident’s data stream. When this occurs, starting and/or ending dates must be imputed and the stay type must be determined as accurately as possible. The following rules will describe how these situations are handling. This discussion will refer to three types of records:

• Entry record (where A0310F= [01]).

• Discharge record (where A0310F= [10, 11, 12]).

• A normal assessment (where A0310F= [99]).

Missing Entry Records

In the scan logic described above, if a normal assessment is immediately preceded chronologically by a discharge record or if there is no chronologically preceding record, then an entry record is missing. In this case the stay start date and type must be imputed. The imputation rules are as explained below. In these rules, the assessment that is preceded chronologically by a discharge or that has no preceding record is termed the “problem assessment”.

The table below is used to impute the entry date when there is a missing entry record.

Table 5-1: Possible Entry Dates When Entry Record is Missing

Type of Problem

Assessment

PPS 5-Day A0310B = [01] A2300 - 7 days A2300

OBRA Admission A0310A = [01] A2300 - 13 days A2300

Other OBRA A0310A = [02,03,04,05,06] A2300 - 106 days A2300

Discharge A0310F = [10,11,12] A1600 A1600

Reasons for

Assessment

Possible Entry Dates

Earliest Date

Latest Date

The table above lists various types of problem assessments and shows the earliest and latest possible entry dates that are associated with each one. The following steps explain how to use this table to impute an entry date and stay type when a problem assessment is chronologically preceded by a discharge assessment or where no record precedes the problem assessment.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 79

Page 84

1. Use the table above to classify the problem assessment. Classify the assessment using

the reason for assessment items indicated in the table. If the problem assessment qualifies for more than one of the rows in the table, use the first (top-most) row for which it qualifies.

2. Determine the earliest and latest entry date associated with the selected row.

3. Determine the entry date (A1600) that is reported on the problem assessment.

4. Determine a tentative entry date, as follows:

4.1. If the entry date (A1600) on the problem assessment falls between the earliest and

latest entry date in the table, set the tentative entry date equal to this value of A1600.

4.2. Otherwise, set the tentative entry date equal to the date that is listed in the “earliest

date” column of the table.

5. Determine a final imputed entry date, as follows:

5.1. If the problem assessment is chronologically preceded by a discharge record, add

one day to the discharge date (A2000) on the discharge record and compare the resulting date with the tentative entry date (A1600 from the assessment). Set the final imputed entry date equal to the later of these two dates.

5.2. If there is no record that chronologically precedes the problem assessment, then set

the final imputed entry date equal to the tentative entry date.

6. Determine the stay type, as follows:

6.1. If the problem assessment is chronologically preceded by a discharge record,

determine the stay type using the normal logic described above.

6.2. If there is no record that chronologically precedes the problem assessment, then set

the stay type as an admission stay.

MISSING DISCHARGE RECORDS

In the scan logic described above, if an entry record is immediately preceded chronologically by a normal assessment, then a discharge record is missing. In this case, the end date of the chronologically preceding stay and the stay type of the current stay must be imputed. The imputation rules are as follows. In these rules, the assessment that chronologically precedes the entry record is termed the “ending index assessment”. The “current stay” is the stay that begins with the entry record. The “chronologically preceding stay” is the stay that contains the ending index assessment.

1. The end date of the chronologically preceding stay is set equal to the assessment

reference date that is recorded on the ending index assessment.

2. Set the stay type of the current stay as follows:

2.1. Determine the value of A1700 that is recorded on the entry record of the current stay.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 80

Page 85

2.2. If A1700 is equal to [1] (admission), then set the stay type for the current stay to

“admission”.

2.3. If A1700 is equal to [2] (reentry), then set the stay type for the current stay to

“reentry”.

Multiple Entry Records

If there are two or more entry records which are adjacent to one another in the resident’s data stream, keep the latest entry record and ignore the earlier adjacent entry record(s).

Multiple Discharge Records

If there are two or more discharge records which are adjacent to one another in the resident’s data stream, keep the latest discharge record and ignore the earlier adjacent discharge record(s).

Sorting Rules

As noted above, stays are identified from the records for a given resident and facility that are sorted in reverse chronological order. Sorting criteria must be applied to handle the case where there is more than one record on a given target date. The exact sorting criteria are as follows:

a) State ID +

b) Facility internal ID + c) Resident internal ID + d) Target date (descending) + e) Record type (descending) + f) Assessment internal ID (descending)

Note that record type (record_type) is defined as follows:

1. If A0310F = 01 (the record is an entry record), then record_type = [1].

2. Else if A0310F = 99 (the record is not an entry or discharge), then:

a. If the item subset code28 is equal to NC (comprehensive assessment), then

record_type = [7].

b. Else if the item subset code is equal to NQ (quarterly assessment), then record_type =

[6].

c. Else if the item subset code is equal to NP (PPS assessment), then record_type = [5].

d. Else record_type = [2] (this condition should not occur).

3. Else if A0310F = [10] (discharge, return not anticipated), then record_type = [8].

4. Else if A0310F = [11] (discharge, return anticipated), then record_type = [9].

The item subset code is contained in the field ITM_SBST_CD.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 81

Page 86

5. Else if A0310F = [12] (death in facility), then record_type = [10].

Also note that the assessment internal ID is used as the final tie-breaker on the assumption that records that should be later in the sort sequence will be submitted and processed later than the other records. The record processing timestamp would be a slightly better field to use for this purpose. However, it is available only to users who have direct access to the ASAP database. The assessment internal ID was therefore adopted as a reasonable substitute for the timestamp so that all users would have access to the same sorting fields.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 82

Page 87

Chapter 6

Specifications for the Facility Characteristics Report

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 83

Page 88

Specifications for Facility Characteristics Report

cord Selection

The Facility Characteristic Report is populated using data from records selected using the standard QM episode and record selection logic as given in the QM User’s Manual. The Facility Characteristics measures can be processed with the QM measures. Each Facility Characteristic measure is computed using all residents (both short-stay and long-stay residents).

Most of the Facility Characteristic measures are populated using data from a look-back scan of the assessment records selected for each resident. For each resident, the look-back scan begins with the target assessment selected for QM processing. The resident’s records are scanned in reverse chronological order (by ARD) and all data items required for the Facility Characteristics report are populated from data that are available from each assessment. As assessments are scanned, each required item is initially populated with the item value from the target assessment. If the value from the target assessment is a valid (non-missing) value, then the scan for that item stops. If the value for the target assessment is not a valid value (a missing value), then the scan continues with the earlier assessments in reverse chronological order. Once a valid value is found for an item, that value is used for the report (i.e., the value is not changed if additional values are present in earlier records).

A “valid value” is any value that is one of the “normal” responses to an item. Missing non-valid values are:

1. A dash (“-”) indicating that the item was not assessed.

2. A caret (“^”) indicating that the item was skipped.

3. A null (.) indicating that the item is inactive.

Note that the diagnosis code items (I8000A through I8000J) are not used in the measure specifications below and are therefore not included in the look-back scan.

For each resident, the look-back scan continues until any of the following conditions is satisfied:

• All required items have been populated with valid values, as defined above, or

• All selected records for a resident have been scanned.

Note that scanning stops for a resident as soon as either of these conditions is satisfied.

Measure Specifications

The definitions in the following table are applied to a look-back scan of the records selected for a resident as described in the prior section on Record Selection. Counts of the number of residents within each facility that meet the numerator criteria for each measure below are used as the numerator to produce facility percentages for the report.

The denominator used to produce the facility percentages in the report will vary for different measures, depending on missing data. If missing data precludes determination of the status for a

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 84

Page 89

measure as indicated in the “Exclusions” section, then the resident is excluded from both the numerator and denominator in the facility percentage.

Table 6-1: Facility Characteristics Report Measure Definitions

Measure Description and Definition

Gender

Male

Female

Age

<25 years old

Description: Resident is included if Item A0800 (Gender) is equal to 1 (Male). Records with dashes (not assessed) in A0800 are excluded from the male/female counts.

Numerator: A0800 = 1 (Male).

Exclusions: A0800 missing

Description: Resident is included if Item A0800 (Gender) is equal to 2

(Female). Records with dashes (not assessed) in A0800 are excluded from the male/female counts.

Numerator: A0800 = 2 (Female).

Exclusions: A0800 missing

Calculation of Age, based on Items A0900 (Birth Date) and A2300 (Assessment Reference Date ARD):

IF (MONTH(A2300) > MONTH(A0900)) OR

(MONTH(A2300) = MONTH(A0900) AND

DAY(A2300) >= DAY(A0900)) THEN Age = YEAR(A2300)-YEAR(A0900) ELSE Age = YEAR(A2300)-YEAR(A0900)-1

Description: Age less than 25 years old.

25-54 years old

55-64 years old

65-74 years old

75-84 years old

Numerator: Record triggers if age < 25.

Description: Age of 25 through 54 years old.

Numerator:

Record triggers if age >= 25 and <= 54.

Description: Age of 55 through 64 years old.

Numerator:

Record triggers if age >= 55 and <= 64.

Description: Age of 65 to 74 years old.

Numerator:

Record triggers if age >= 65 and <= 74.

Description: Age of 75 through 84 years old.

Numerator:

Record triggers if age >= 75 and <= 84.

(continued)

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 85

Page 90

Table 6-1: Facility Characteristics Report Measure Definitions (continued)

Measure

Description and Definition

85+ years old

Diagnostic Characteristics

Psychiatric Diagnosis

Intellectual Disability (ID) (Mental retardation as defined at 483.45(a)) or Developmental Disability (DD)

Description: Age of 85 years of age or older.

Numerator:

Record triggers if age >= 85.

Description: Resident is included as having a psychiatric diagnosis if any of the following is true:

• Any psychiatric mood disorders are checked (=1) in items I5700 through I6100, or

• Item I5350 (Tourette’s Syndrome) is checked (=1), or

• Item I5250 (Huntington’s Disease) is checked (=1).

Numerator:

• Any of the following items are checked (-1): I5250, I5350, I5700 through I6100.

Exclusions: No value I5250, I5350, I5700 through I6100 = 1 and any

value I5250, I5350, I5700 through I6100 is missing

Description: Resident is counted as having ID/DD if any of the following items are checked:

•

A1550A (Down syndrome). A1550B (Autism).

•

A1550C (Epilepsy).

•

A1550D (Other organic condition related to ID/DD).

•

A1550E (ID/DD with no organic condition).

Hospice

Numerator:

A1550A, B, C, D, or E is checked (= 1).

Exclusions: No value A1550A, B, C, D, or E = 1 and any value A1550A, B, C, D, or E missing

Description: Resident is included if Item O0100K2 (Hospice care) is checked.

Numerator: O0100K2 is checked (=1).

Exclusions: O0100K2 missing

(continued)

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 86

Page 91

Table 6-1: Facility Characteristics Report Measure Definitions (continued)

Measure

Description and Definition

Prognosis

Life expectancy of less than 6 months

Discharge Plan

Discharge planning IS NOT already occurring for the resident to return to the community.

Discharge planning IS already occurring for the resident to return to the community.

Referral

Referral not needed.

Description: Resident is included if item J1400 (Prognosis) is coded 1 (Yes).

Numerator: J1400 = 1 (Yes).

Exclusions: J1400 missing

Description: Resident is included if Item Q0400A (Discharge Plan) is coded 0 (No).

Numerator: Q0400A = 0 (No).

Exclusions: Q0400A missing

Description: Resident is included if Item Q0400A (Discharge Plan) is coded 1 (Yes).

Numerator: Q0400A = 1 (Yes).

Exclusions: Q0400A missing

Description: Resident is included if Item Q0600 (Referral) is coded 0 (No

- Referral not needed).

Referral is or may be needed, but has not been made.

Referral has been made.

Numerator: Q0600 = 0 (No - Referral not needed).

Exclusions: Q0600 missing

Description: Resident is included if Item Q0600 (Referral) is coded 1

(Yes – Referral is or may be needed).

Numerator: Q0600 = 1 (No - Referral is or may be needed).

Exclusions: Q0600 missing

Description: Resident is included if Item Q0600 (Referral) is coded 2

(Yes - Referral made).

Numerator: Q0600 = 2 (Yes - Referral made).

Exclusions: Q0600 missing

(continued)

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 87

Page 92

Table 6-1: Facility Characteristics Report Measure Definitions (continued)

Measure

Description and Definition

Type of Entry

Admission

Reentry

Entered Facility From

Community (private home/apartment board/care, assisted living, group home)

Another nursing home or swing bed

Description: Resident is included if Item A1700 (Type of Entry) is coded 1, (Admission).

Numerator: A1700 = 1 (Admission).

Exclusions: A1700 missing

Description: Resident is included if Item A1700 (Type of Entry) is coded 2, (Reentry).

Numerator: A1700 = 2 (Reentry).

Exclusions: A1700 missing

Description: Resident is included if Item A1800 (Entered From) is coded 01 (Community).

Numerator: A1800 = 01 (Community).

Exclusions: A1800 missing

Description: Resident is included if Item A1800 (Entered From) is coded 02 (Another nursing home or swing bed).

Acute hospital

Psychiatric hospital

Inpatient rehabilitation facility

Numerator: A1800 = 02 (Another nursing home or swing bed).

Exclusions: A1800 missing

Description: Resident is included if Item A1800 (Entered From) is coded 03 (Acute hospital).

Numerator: A1800 = 03 (Acute hospital).

Exclusions: A1800 missing

Description: Resident is included if Item A1800 (Entered From) is coded 04 (Psychiatric hospital).

Numerator: A1800 = 04 (Psychiatric hospital).

Exclusions: A1800 missing

Description: Resident is included if Item A1800 (Entered From) is coded 05 (Inpatient rehabilitation facility).

Numerator: A1800 = 05 (Inpatient rehabilitation facility).

Exclusions: A1800 missing

(continued)

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 88

Page 93

Table 6-1: Facility Characteristics Report Measure Definitions (continued)

Measure

Description and Definition

ID/DD facility

Hospice

Long Term Care Hospital (LTCH)

Other

Description: Resident is included if Item A1800 (Entered From) is coded 06 (ID/DD facility).

Numerator: A1800 = 06 (ID/DD facility).

Exclusions: A1800 missing

Description: Resident is included if Item A1800 (Entered From) is coded 07 (Hospice).

Numerator: A1800 = 07 (Hospice).

Exclusions: A1800 missing

Description: Resident is included if Item A1800 (Entered From) is coded 09 (Long Term Care Hospital (LTCH)).

Numerator: A1800 = 09 (Long Term Care Hospital (LTCH)).

Exclusions: A1800 missing

Description: Resident is included if Item A1800 (Entered From) is coded 99 (Other).

Numerator: A1800 = 99 (Other).

Exclusions: A1800 missing

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 89

Page 94

MDS 3.0 Quality Measures

USER’S MANUAL

APPENDIX A

Quality Measure Identification Number

by CMS Reporting Module

Effective: October 1, 2020

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 A-1

Page 95

Quality Measure Identification Number by CMS Reporting Module V1.8

The table below documents CMS quality measures (QM) calculated using MDS 3.0 data and reported in a CMS reporting module. A unique CMS identification number (ID) is specified for each QM. The table serves two purposes:

• The table indicates which QMs are associated with a CMS reporting module.

• The table documents the CMS ID—the link to QM specification detail in the CMS’ MDS

QM User’s Manual. As various QM specifications are revised, the QM is given a new CMS ID and the older QM logical version (i.e., CMS ID) is retained. This allows for the possibility of a transition period when more than one version of the same QM can be reported simultaneously across reporting modules (e.g., a MDS 3.0 item set update). The National Quality Forum (NQF) identification number is included for reference.

The following CMS reporting modules are included:

CASPER Reporting Quality Measure Reports contain quality measure information at the

national, state, facility and resident level for a single reporting period. Users are able to specify the reporting time frame. State and National comparison group data are calculated monthly on the first day of the month. Data calculation is delayed by two months in order to allow for submission of late and corrected assessments. Comparison data are not recalculated if assessments with target dates that fall in periods for which comparison group data were already calculated. Quality Measure data are calculated weekly for the assessments accepted into the national database since the previous week’s data calculation.

Note: Quality measure reports available to facilities through CMS’s CASPER reporting

system are also available to State Surveyors.

Nursing Home Compare (NHC), CMS’ website contains quality measure information (as well

as other details) for Medicare and Medicaid-certified US nursing homes. (Note: information for those nursing homes reporting less than 20 residents for both short stay and long stay quality measures for the reporting period is not included.). The QM information is updated and posted quarterly. NHC reports the average adjusted QM values across the most recent four quarters.

Five-Star Quality Rating System contains information on health inspections, staffing and

quality measures. QMs are updated and posted quarterly. The Five Star module reports the weighted average adjusted QM values across the most recent four quarters.

Facility and Resident Quality Measure Preview Reports, available in the facility’s shared

folders on CMS’ QIES website, display the quarterly numerator, denominator and reported percent values for each of the publicly reported MDS 3.0 quality measures and also displays the list of residents who triggered one or more of the publicly reported MDS 3.0 Quality Measures. The preview reports allow the provider to see their measure percent values prior to being posted on the Nursing Home Compare website. The preview reports indicate the

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 A-2

Page 96

measure values for the most recent quarter (i.e., the QM value is based on a one quarter look back period). The quality measure data correspond with the NHC reporting cycle.

QMs by CMS Reporting Module—Column Headers

Quality Measure Label: A brief definition of the quality measure. The label refers to the one sentence definition of the QM as reported in the MDS 3.0 QM User’s Manual. The QM label wording may not be identical across reporting modules. The User should refer to the CMS ID for QM cross-reference among reporting modules.

Short or Long Stay: Refers to the nursing home (NH) population used to calculate the quality measure. The short stay quality measure specifications are based on NH residents whose episode is less than or equal to 100 cumulative days in the nursing home at the end of the target period. The long stay quality measure specifications are based on NH residents whose episode is greater than or equal to 101 cumulative days in the NH at of the end of the target period.

CMS ID: the unique CMS identification number depicted as

S = provider type (N = Nursing Home) nnn = three-digit QM ID vv = logic version number for a QM (e.g., 01, 02, 03)

Examples of incrementing the CMS ID:

N123.01 – first logic version of the nursing home measure 123 N123.02– second logic version of nursing home measure 123

NQF ID: Specifies the National Quality Forum QM identification number for those QM endorsed by NQF. For further details refer to the National Quality Forum website:

https://www.qualityforum.org/qps/

Effective Date: Specifies the date the QM was first implemented (i.e., effective).

CASPER: Certification and Survey Provider Enhanced Reports (CASPER) Quality Measure

Reports. For further details refer to references and manuals page of the QIES Technical Support Office website: https://qtso.cms.gov/providers/nursing-home-mdsswing-bed-

providers/reference-manuals

NHC: CMS’ Nursing Home Compare website contains detailed information about all Medicare and Medicaid-certified nursing homes in the US, including quality measures. For further details refer to the Nursing Home Compare website:

https://www.medicare.gov/NursingHomeCompare/search.aspx?bhcp=1

Five-Star: CMS’ Five-Star Quality Rating System contains information on health inspections, staffing and quality measures. For further details see the Nursing Home Compare Five-Star Quality Rating System Technical Users’ Guide: https://www.cms.gov/Medicare/Provider-

Enrollment-and-Certification/CertificationandComplianc/Downloads/cutpointstable.pdf

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 A-3

Page 97

Provider Preview: Facility and Resident Quality Measure Preview Reports. For further details refer to the QIES Technical Support Office website: https://qtso.cms.gov/

Specifications for all CMS ID quality measures are contained in Chapter 2 of this user’s manual.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 A-4

Page 98

0682A

drawn)

Table A-1: Quality Measures (QMs) by CMS Reporting Module – Short Stay

Quality Measure (QM) Label CMS ID NQF ID

SHORT STAY QMs

Changes in Skin Integrity Post-Acute Care: Pressure Ulcer/Injury

S038.02 NA 10/1/20

Percent of Residents Who Were Assessed and Appropriately Given the

N003.03 0680 10/1/12 NO

Seasonal Influenza Vaccine

Percent of Residents Who Received the Seasonal Influenza Vaccine

N004.03 0680A 10/1/12 NO NO NO

Percent of Residents Who Were Offered and Declined the Seasonal Influenza

N005.03 0680B 10/1/12 NO NO NO

Vaccine

Percent of Residents Who Did Not Receive, Due to Medical Contraindication, the Seasonal Influenza

N006.03 0680C 10/1/12 NO NO NO

Vaccine

Percent of Residents Assessed and Appropriately Given the Pneumococcal Vaccine

N007.02

0682

(with-

drawn)

Effective

Date CASPER29 NHC

YES YES YES YES

10/1/12 NO

YES

Five-

Star

Provider

Preview

YES

Percent of Residents Who Received the Pneumococcal Vaccine

N008.02

(with-

10/1/12 NO NO NO

YES

The quality measure reports available to facilities through CASPER are also available to State Surveyors.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 A-5

Page 99

Quality Measure (QM) Label CMS ID NQF ID

SHORT STAY QMs

Percent of Residents Who Were Offered and Declined the Pneumococcal Vaccine

Percent of Residents Who Did Not Receive, Due to Medical Contraindication, the Pneumococcal Vaccine

Percent of Residents Who Newly Received an Antipsychotic Medication

Percentage of Residents Who Made Improvements in Function

Effective

Date CASPER29 NHC

0682B

N009.02

(with-

10/1/12 NO NO NO

drawn)

0682C

N010.02

(with-

10/1/12 NO NO NO

drawn)

N011.02 NA 4/1/12

N037.03 NA 10/1/16

Five-

Star

Provider

Preview

YES

YES YES YES YES

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 A-6

Page 100

Table A-2: Quality Measures (QMs) by CMS Reporting Module – Long Stay

Quality Measure (QM) Label CMS ID NQF ID

LONG STAY QMs

Percent of Residents Experiencing One or More Falls with Major Injury

Percent of High-Risk Residents with Pressure Ulcers

N013.02 0674 10/1/10

N015.03 0679 10/1/18

Percent of Residents Assessed and Appropriately Given the Seasonal

N016.03 0681 10/1/10 NO

Influenza Vaccine

Percent of Residents Who Received the Seasonal Influenza Vaccine

N017.03 0681A 10/1/10 NO NO NO

Percent of Residents Who Were Offered and Declined the Seasonal Influenza

N018.03 0681B 10/1/10 NO NO NO

Vaccine

Percent of Residents Who Did Not Receive, Due to Medical Contraindication, the Seasonal Influenza

N019.03 0681C 10/1/10 NO NO NO

Vaccine

Effective

Date CASPER30 NHC

YES YES YES YES

YES

Five-

Star

Provider

Preview

YES

Percent of Residents Assessed and Appropriately Given the Pneumococcal Vaccine

N020.02

0683

(with-

drawn)

10/1/10 NO

YES

The quality measure reports available to facilities through CASPER are also available to State Surveyors.

MDS 3.0 Quality Measures User’s Manual V14 – Effective October 1, 2020 A-7